WO2024098530A1 - Intermediate and method for preparing pyrroloquinoline quinone - Google Patents

Intermediate and method for preparing pyrroloquinoline quinone Download PDF

Info

Publication number
WO2024098530A1
WO2024098530A1 PCT/CN2022/142378 CN2022142378W WO2024098530A1 WO 2024098530 A1 WO2024098530 A1 WO 2024098530A1 CN 2022142378 W CN2022142378 W CN 2022142378W WO 2024098530 A1 WO2024098530 A1 WO 2024098530A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
formula
quinoline
prepare
pyrrolo
Prior art date
Application number
PCT/CN2022/142378
Other languages
French (fr)
Chinese (zh)
Inventor
蔡成法
王靖林
穆振强
刘桂贞
于瑞梅
廉琼琼
田翠翠
Original Assignee
山东原力泰医药科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 山东原力泰医药科技有限公司 filed Critical 山东原力泰医药科技有限公司
Publication of WO2024098530A1 publication Critical patent/WO2024098530A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • C07C251/74Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/76Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Definitions

  • the present application relates to the field of preparation of organic compounds, and in particular to an intermediate and method for preparing pyrroloquinoline quinone.
  • pyrroloquinoline quinone also known as pyrroloquinoline quinone (PQQ, methoxatin), CAS No. 72909-34-3
  • PQQ pyrroloquinoline quinone
  • CAS No. 72909-34-3 pyrroloquinoline quinone
  • PQQ is widely present in various common foods such as fruits, vegetables, grains and beverages, including plant-derived foods and animal-derived foods.
  • concentration of PQQ available in food sources is very low, only at the level of nanograms to micrograms per kilogram. Therefore, it is impossible to obtain sufficient PQQ through dietary supplementation alone, and chemical synthesis of PQQ becomes inevitable.
  • Corey et al. first achieved the total synthesis of PQQ, referred to as the Corey method, see Corey E J, Tramontano A. Total synthesis of the quinonoid alcohol dehydrogenase coenzyme (1) of methylotrophic bacteria [J]. Journal of the American Chemical Society, 1981, 103 (18): 5599-5600. According to Corey's report, PQQ can be prepared by total synthesis from commercial raw materials through a 10-step chemical process. Subsequently, Martin et al. improved the route of the Corey method and reduced the total synthesis steps to 9 steps, referred to as the Martin method, see Martin P, Steiner E, Auer K, et al. Zur compassion von PQQ in kg-Mengen [J].
  • ANTHEM BIOSCIENCES PVT provided a PQQ synthesis method, see patent WO2014/195896. The difference of this method is that methyl halobenzene is used as a raw material to synthesize PQQ on a large scale.
  • the above method and the existing route involving the total chemical synthesis of PQQ must be used in the latter stage of the reaction to mildly oxidize the methoxy-pyrroloquinoline intermediate to the pyrroloquinoline quinone intermediate by ammonium cerium nitrate (CAN).
  • the present application provides an intermediate and method for preparing pyrroloquinoline quinone.
  • the reaction route for preparing pyrroloquinoline quinone with the intermediate of the present application is simple, the reaction yield is high, the purity is good, the reaction conditions are mild, and the reaction raw materials of the present application are cheap and easy to obtain, which can greatly reduce the reaction cost, and the reaction route can be controlled within 6 steps or less, which greatly simplifies the reaction route and improves the reaction efficiency, significantly shortens the production cycle, and the method of the present application is easy to scale up, and the production scale can reach the hundred-gram level, which can realize large-scale production.
  • the present application provides compounds as shown in Formula I and Formula II, whose structural formula is:
  • R1 is a C1 - C3 straight chain or branched alkyl group
  • R2 is a nitro group or an amino group
  • R3 is selected from hydrogen and a C1 - C3 straight chain or branched alkyl group.
  • R 1 , R 2 and R 3 are as defined above.
  • R 1 is preferably methyl or ethyl.
  • R 3 is preferably hydrogen, methyl, ethyl or propyl.
  • the present application provides the use of a compound of formula I, a compound of formula II or a compound of formula X as an intermediate in the preparation of 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid (also known as pyrroloquinoline quinone, PQQ or methoxatin);
  • R 1 , R 2 and R 3 are as defined above.
  • the intermediate compound that can be used to prepare pyrroloquinoline quinone in the first aspect above is selected from the following structures:
  • the reaction yield is high and the purity is good.
  • the reaction is simple and the conditions are mild.
  • the reaction route can be achieved in only 6 steps, which greatly simplifies the reaction method and improves the reaction efficiency.
  • the reaction raw materials are cheap and easily available, which greatly reduces the cost of the reaction.
  • the above-mentioned intermediate compounds are used to prepare pyrroloquinoline quinone, which is easy to scale up and can be produced on a large scale.
  • the present application provides a method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the method comprising: preparing a compound of formula III from a compound of formula II by Fischer indole synthesis, then hydrolyzing the compound of formula III to prepare a compound of formula IV, and finally oxidizing the compound of formula IV to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid;
  • R 1 and R 3 are as defined above;
  • R1 is methyl or ethyl
  • R3 is selected from hydrogen, methyl, ethyl and propyl.
  • the compound of formula II can be prepared by reacting a compound of formula I-2 with a compound of formula V under the catalysis of Lewis acid.
  • R 1 and R 3 are as defined above.
  • R1 is methyl or ethyl
  • R3 is selected from hydrogen, methyl, ethyl and propyl.
  • the present application provides a method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the method comprising: preparing a compound of formula II from a compound of formula I-2 and a compound of formula V under Lewis acid catalysis, then preparing a compound of formula III from the compound of formula II by Fischer indole synthesis, then hydrolyzing the compound of formula III to prepare a compound of formula IV, and finally oxidizing the compound of formula IV to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid;
  • R 1 and R 3 are as defined above.
  • R1 is methyl or ethyl
  • R3 is selected from hydrogen, methyl, ethyl and propyl.
  • the compound of formula I-2 can be prepared by reducing the compound of formula I-1.
  • the present application provides a method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the method comprising: reducing a compound of formula I-1 to prepare a compound of formula I-2, then reacting the compound of formula I-2 with a compound of formula V under Lewis acid catalysis to prepare a compound of formula II, then reacting the compound of formula II to prepare a compound of formula III by Fischer indole synthesis, then hydrolyzing the compound of formula III to prepare a compound of formula IV, and finally oxidizing the compound of formula IV to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid;
  • R 1 and R 3 are as defined above.
  • R1 is methyl or ethyl
  • R3 is selected from hydrogen, methyl, ethyl and propyl.
  • the compound of formula I-1 can be prepared by diazotizing 3,4-dialkoxy-5-nitroaniline (such as the compound of formula X) and condensing it with ethyl 2-methylacetoacetate, wherein R 1 is as defined above.
  • the present application provides a method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the method comprising: 3,4-dialkoxy-5-nitroaniline (compound of formula X) is diazotized and then condensed with ethyl 2-methylacetoacetate to prepare a compound of formula I-1, the compound of formula I-1 is reduced to prepare a compound of formula I-2, and then the compound of formula I-2 and the compound of formula V are catalyzed by Lewis acid to prepare a compound of formula II, and then the compound of formula II is prepared by Fischer indole synthesis to prepare a compound of formula III, and then the compound of formula III is hydrolyzed to prepare a compound of formula IV, and finally the compound of formula IV is oxidized to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quino
  • R 1 and R 3 are as defined above.
  • R1 is methyl or ethyl
  • R3 is selected from hydrogen, methyl, ethyl and propyl.
  • the 3,4-dialkoxy-5-nitroaniline (compound of formula X) can be prepared using 3,4-dialkoxy-5-nitrobenzoic acid or 3,4-dialkoxy-5-nitrobenzamide as a raw material, wherein R 1 is as defined above.
  • the last oxidation step in the above preparation method i.e., the step of oxidizing the compound of formula IV to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid
  • the protonic acid may be hydrobromic acid, hydroiodic acid or hydrochloric acid.
  • the oxidant may be hydrogen peroxide, concentrated sulfuric acid, concentrated nitric acid or ozone.
  • the advantages of the present application are: when the intermediate described in the present application is used to prepare pyrroloquinoline quinone, the reaction route is simple, the reaction yield is high (the single-step yield is above 75%, and the total yield is significantly improved), the purity is good, the reaction conditions are mild, and the reaction raw materials of the present application are cheap and easy to obtain, which can greatly reduce the reaction cost.
  • the reaction route can be controlled within 6 steps or less, which greatly simplifies the reaction route and improves the reaction efficiency, shortens the reaction cycle, and the method of the present application is easy to scale up, and the production scale can reach the hundred-gram level, which can be mass-produced.
  • FIG1 is a hydrogen spectrum of an exemplary compound of formula I-1.
  • FIG2 is a carbon spectrum of an exemplary compound of formula I-1.
  • FIG3 is a hydrogen spectrum of an exemplary compound of formula I-2.
  • FIG4 is a carbon spectrum of an exemplary compound of formula I-2.
  • reagents or raw materials used in this application can be purchased through conventional channels. Unless otherwise specified, the reagents or raw materials used in this application are used in a conventional manner in the art or in accordance with the product instructions. In addition, any method and material similar to or equivalent to the content described herein can be applied to the method of this application. The preferred implementation methods and materials described in the text are for demonstration purposes only.
  • the present application provides compounds of formula I and formula II and methods for preparing the same, as well as a method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid using compounds of formula I, formula II and/or formula X as intermediates.
  • the method for preparing pyrroloquinoline quinone using formula II as an intermediate can be carried out according to the following reaction scheme:
  • R1 is a C1 - C3 straight chain or branched chain alkyl group
  • R3 is selected from hydrogen and a C1 - C3 straight chain or branched chain alkyl group.
  • R1 is a methyl group or an ethyl group
  • R3 is a methyl group, an ethyl group or a propyl group.
  • the quinoline in the structure can play a placeholder role to improve the selectivity of indole synthesis, avoid the generation of unnecessary side reaction substances, greatly improve the synthesis efficiency and yield, and reduce the subsequent complicated purification work.
  • the method for preparing pyrroloquinoline quinone using Formula I as an intermediate can be carried out according to the following reaction route:
  • R1 is a C1 - C3 straight chain or branched chain alkyl group
  • R2 is an amino group
  • R3 is selected from hydrogen and a C1 - C3 straight chain or branched chain alkyl group.
  • R1 is a methyl group or an ethyl group
  • R3 is a methyl group, an ethyl group or a propyl group.
  • reaction route can be:
  • R1 is a C1 - C3 straight chain or branched chain alkyl group
  • R3 is selected from hydrogen and a C1 - C3 straight chain or branched chain alkyl group.
  • R1 is a methyl group or an ethyl group
  • R3 is a methyl group, an ethyl group or a propyl group.
  • the reaction route of the present application when preparing pyrroloquinoline quinone using the compound of formula I as an intermediate, the quinoline structure is first synthesized, and then the Fischer indole synthesis is performed.
  • the selectivity of the indole synthesis is improved by the quinoline occupancy, the generation of unnecessary side reaction substances is avoided, the synthesis efficiency and yield are greatly improved, and the subsequent complicated purification work is reduced.
  • the method for preparing pyrroloquinoline quinone using a 3,4-dialkoxy-5-nitroaniline compound can be carried out according to the following reaction route:
  • R1 is a C1 - C3 straight chain or branched chain alkyl group
  • R3 is selected from hydrogen and a C1 - C3 straight chain or branched chain alkyl group.
  • R1 is a methyl group or an ethyl group
  • R3 is a methyl group, an ethyl group or a propyl group.
  • 3,4-dialkoxy-5-nitroaniline compound (compound of formula X) is used as an intermediate to prepare pyrroloquinoline quinone by first synthesizing the quinoline structure and then performing the Fischer indole synthesis.
  • the selectivity of the indole synthesis is improved by quinoline occupation, the generation of unnecessary side reaction substances is avoided, the synthesis efficiency and yield are greatly improved, and the subsequent complicated purification work is reduced.
  • the last step of the above-mentioned multiple reactions is an oxidation reaction, which can be carried out in one step or according to the following reaction route:
  • the preparation method of pyrroloquinoline quinone includes:
  • the molar ratio of the compound of formula X to ethyl 2-methylacetoacetate is 1:1-5.
  • the temperature of the reaction stage of step (1) is controlled at -10°C to 0°C.
  • step (1) comprises: stirring and mixing anhydrous ethanol as a solvent and a compound of formula X, cooling the reaction system to -10°C-0°C, adding an acid (such as concentrated hydrochloric acid or concentrated sulfuric acid), maintaining the reaction system temperature at -10°C-0°C, adding sodium nitrite, stirring at -10°C-0°C, adding ethyl 2-methylacetoacetate, and adding sodium acetate, and stirring and reacting at -10°C-0°C.
  • an acid such as concentrated hydrochloric acid or concentrated sulfuric acid
  • the compound of formula I-1 is subjected to a reduction reaction with a reducing agent such as iron powder in an acetic acid solution, and the reaction temperature is controlled at 60-80°C.
  • a reducing agent such as iron powder in an acetic acid solution
  • the molar ratio of the compound of formula I-2 to the compound of formula V is 1:1-5.
  • step (3) comprises: after the compound of formula I-2 and a solvent (such as dichloromethane) are stirred evenly, a compound of formula V and a Lewis acid (such as zinc chloride) are added, and the reaction is stirred at room temperature.
  • a solvent such as dichloromethane
  • a Lewis acid such as zinc chloride
  • the reaction temperature is controlled at 30-55°C.
  • step (4) comprises: uniformly stirring excess sulfuric acid and compound II, heating the reaction system to 30-55° C. and stirring the reaction.
  • the ester hydrolysis reaction occurs in an alkaline environment and the temperature is controlled at 80-90°C.
  • intermediate E can be prepared by reacting with a protonic acid to obtain intermediate F, and the protonic acid can be hydrobromic acid, hydrochloric acid or hydroiodic acid, preferably hydroiodic acid; for example, the oxidation can use an oxidant, and the oxidant can be selected from one or more of hydrogen peroxide, concentrated sulfuric acid, concentrated nitric acid and ozone, preferably hydrogen peroxide.
  • the protonic acid can be hydrobromic acid, hydrochloric acid or hydroiodic acid, preferably hydroiodic acid
  • the oxidation can use an oxidant, and the oxidant can be selected from one or more of hydrogen peroxide, concentrated sulfuric acid, concentrated nitric acid and ozone, preferably hydrogen peroxide.
  • the room temperature in the experiments of this application refers to 20-25°C.
  • the starting reactant 3,4-dimethoxy-5-nitroaniline can be prepared using 3,4-dimethoxy-5-nitrobenzoic acid or 3,4-dimethoxy-5-nitrobenzamide as raw materials.
  • 3,4-dimethoxy-5-nitroaniline can be prepared according to the method in U.S. Pat. No. 5,236,952, and the relevant contents of the patent are incorporated into this application by reference.
  • 3,4-dimethoxy-5-nitroaniline can be prepared according to the following method:
  • 3,4-diethoxy-5-nitrobenzoic acid is used as a raw material to replace 3,4-dimethoxy-5-nitrobenzoic acid to prepare 3,4-diethoxy-5-nitroaniline.
  • the above-mentioned charging reaction is carried out multiple times to accumulate 3,4-dimethoxy-5-nitroaniline material and 3,4-diethoxy-5-nitroaniline material for the preparation of the target product.
  • the following examples illustrate the preparation process of the intermediates described in the present application and the specific process of preparing PQQ using the intermediates described in the present application under certain conditions.
  • the following examples are examples of preparing products at the 100-gram level. In order to accumulate sufficient materials for each step of the reaction, the following examples will perform multiple feeding reactions in actual operations, and each feeding process is the same.
  • the following preparation examples only illustrate a single feeding preparation process.
  • (Z)-2-(2-(3,4-diethoxy-5-nitrophenyl)hydrazine)ethyl propionate (compound formula I-1-2) can be prepared according to the method described in Preparation Example 1-3, with a molar yield of more than 85% and an HPLC purity of more than 95%.
  • N-(5-amino-3-bromo-2-methoxyphenyl)acetamide was used as an intermediate to prepare PQQ.
  • the reaction was carried out according to the following reaction route:
  • the molar yield can be maintained at more than 75% when synthesizing the quinoline ring, and the HPLC purity is more than 99%; at the same time, the bromine atom on the benzene ring of the starting material needs to be converted from -Br to -OCH3 through the Ullmann reaction in the sixth step, and the reaction route becomes longer, resulting in a further decrease in the final yield and purity, and the total yield of the reaction route is less than 20%.
  • the existing intermediates for preparing PQQ often have this problem, so the intermediates in the prior art will choose to close the indole ring first and then close the quinoline ring.
  • reaction solution After the reaction is completed, cool the reaction solution to 30°C, adjust the pH value of the filtrate to 2-3 with dilute sulfuric acid, precipitate a large amount of crystals, cool, filter, and dry to obtain 325.8g of compound G, with a molar yield of 90.5% and HPLC purity of 99.2%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present application provides an intermediate and method for preparing pyrroloquinoline quinone. The method comprises: using a compound of formula (II) as a starting raw material to prepare a compound of formula (III) by means of a Fischer indole synthesis method, hydrolyzing the compound of formula (III) to prepare a compound of formula (IV), and oxidizing the compound of formula (IV) to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, wherein R1 is C1-C3 linear or branched alkyl, and R3 is selected from hydrogen and C1-C3 linear or branched alkyl. The method is simple, the yield is high, the reaction conditions are mild, the operation is simple, the production period is obviously shortened, the method of the present application is easy to scale up, the production scale can reach a hundred-gram level, and large-scale production can be realized.

Description

制备吡咯喹啉醌的中间体及方法Intermediates and methods for preparing pyrroloquinoline quinone
本发明要求于2022年11月11日提交中国专利局、申请号为202211415318.7、发明名称为“制备吡咯喹啉醌的中间体及方法”的中国专利申请的优先权,其全部内容通过引用结合在本发明中。The present invention claims the priority of the Chinese patent application filed with the Chinese Patent Office on November 11, 2022, with application number 202211415318.7 and invention name “Intermediates and methods for preparing pyrroloquinoline quinone”, the entire contents of which are incorporated by reference into the present invention.
技术领域Technical Field
本申请涉及有机化合物制备领域,具体涉及一种制备吡咯喹啉醌的中间体及方法。The present application relates to the field of preparation of organic compounds, and in particular to an intermediate and method for preparing pyrroloquinoline quinone.
背景技术Background technique
本申请背景技术中公开的信息旨在增加对本申请总体背景的理解,而该公开不应必然被视为承认或以任何形式暗示该信息已经成为本领域一般技术人员所公知的现有技术。The information disclosed in the background technology of this application is intended to increase the understanding of the overall background of this application, and this disclosure should not necessarily be regarded as an admission or any form of suggestion that this information has become the prior art known to ordinary technicians in this field.
4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸,又名吡咯喹啉醌(PQQ,methoxatin),CAS号为72909-34-3,是一种天然产物。PQQ广泛存在于水果、蔬菜、谷物和饮品等各种常见食物中,包括植物源性食物和动物源性食物。然而,PQQ在食物来源中可获得的浓度很低,仅为纳克至微克/公斤的水平。因此,仅以膳食补充无法获取充足的PQQ,化学合成PQQ成为必然。4,5-Dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, also known as pyrroloquinoline quinone (PQQ, methoxatin), CAS No. 72909-34-3, is a natural product. PQQ is widely present in various common foods such as fruits, vegetables, grains and beverages, including plant-derived foods and animal-derived foods. However, the concentration of PQQ available in food sources is very low, only at the level of nanograms to micrograms per kilogram. Therefore, it is impossible to obtain sufficient PQQ through dietary supplementation alone, and chemical synthesis of PQQ becomes inevitable.
Corey等人首次实现了PQQ的全合成,简称Corey方法,参见Corey E J,Tramontano A.Total synthesis of the quinonoid alcohol dehydrogenase coenzyme(1)of methylotrophic bacteria[J].Journal of the American Chemical Society,1981,103(18):5599-5600。根据Corey的报道,可以通过10步化学过程,从商业原料全合成制备PQQ。其后,Martin等改进了Corey方法的路线,将其全合成步骤缩减到9步,简称Martin方法,参见Martin P,Steiner E,Auer K,et al.Zur Herstellung von PQQ in kg‐Mengen[J].Helvetica chimica acta,1993,76(4):1667-1673。2006年,Kempf等通过组合Corey方法和Martin方法的路线大规模合成PQQ,简称Kempf方法,参见WO2006/102642A1。Corey方法和Martin方法均难以实现克级规模PQQ的制备,其中Corey方法仅能获得50mg规模的PQQ,该方法适用于实验室制备,难以工业化应用,虽然Martin方法相较于Corey方法合成步骤得以缩减,但是总体工艺路线非常相似,合成规模没有得到明显提高,尤其是它在合成的最后一步还需要一个繁琐的两阶段分离过程。虽然Kempf方法能够实现克级规模PQQ的生产,但其进一步要求用硫酸提纯最终化合物,且多步骤涉及中间体的分离工作,过程繁琐。2014年,ANTHEM BIOSCIENCES PVT公司提供了一种PQQ合成方法,参见专利WO2014/195896,该 方法的不同之处在于采用甲基卤苯为原料大规模合成PQQ,但是上述方法以及现有涉及PQQ化学全合成的路线,其反应后段必须通过硝酸铈铵(CAN)将甲氧基-吡咯喹啉中间体温和氧化为吡咯喹啉醌中间体。虽然该过程产物选择性较高,但是硝酸铈铵消耗量极大(一般为原料质量用量的8倍以上),而且最后的分离和纯化困难,导致该步骤的最优化收率仅为60%左右。加之硝酸铈铵价格高昂,导致PQQ总体合成成本居高不下,而且铈盐只能作为废物处理,排污压力大。此外,由于该过程效率很低,使得PQQ的生产难以实现高效化和工业化。Corey et al. first achieved the total synthesis of PQQ, referred to as the Corey method, see Corey E J, Tramontano A. Total synthesis of the quinonoid alcohol dehydrogenase coenzyme (1) of methylotrophic bacteria [J]. Journal of the American Chemical Society, 1981, 103 (18): 5599-5600. According to Corey's report, PQQ can be prepared by total synthesis from commercial raw materials through a 10-step chemical process. Subsequently, Martin et al. improved the route of the Corey method and reduced the total synthesis steps to 9 steps, referred to as the Martin method, see Martin P, Steiner E, Auer K, et al. Zur Herstellung von PQQ in kg-Mengen [J]. Helvetica chimica acta, 1993, 76 (4): 1667-1673. In 2006, Kempf et al. synthesized PQQ on a large scale by combining the Corey method and the Martin method, referred to as the Kempf method, see WO2006/102642A1. Both the Corey method and the Martin method are difficult to achieve the preparation of PQQ on a gram scale. The Corey method can only obtain PQQ on a 50 mg scale. This method is suitable for laboratory preparation and difficult to apply industrially. Although the Martin method has fewer synthesis steps than the Corey method, the overall process route is very similar and the synthesis scale has not been significantly improved, especially in the last step of the synthesis, it still requires a cumbersome two-stage separation process. Although the Kempf method can achieve the production of gram-scale PQQ, it further requires the purification of the final compound with sulfuric acid, and multiple steps involve the separation of intermediates, which is a cumbersome process. In 2014, ANTHEM BIOSCIENCES PVT provided a PQQ synthesis method, see patent WO2014/195896. The difference of this method is that methyl halobenzene is used as a raw material to synthesize PQQ on a large scale. However, the above method and the existing route involving the total chemical synthesis of PQQ must be used in the latter stage of the reaction to mildly oxidize the methoxy-pyrroloquinoline intermediate to the pyrroloquinoline quinone intermediate by ammonium cerium nitrate (CAN). Although the product selectivity of this process is high, the consumption of ammonium cerium nitrate is extremely large (generally more than 8 times the mass of the raw material), and the final separation and purification are difficult, resulting in the optimized yield of this step being only about 60%. In addition, the high price of ammonium cerium nitrate leads to the high overall synthesis cost of PQQ, and the cerium salt can only be treated as waste, which has a high sewage discharge pressure. In addition, due to the low efficiency of the process, it is difficult to achieve high efficiency and industrialization in the production of PQQ.
发明内容Summary of the invention
本申请提供了制备吡咯喹啉醌的中间体及方法。以本申请的中间体制备吡咯喹啉醌反应路线简单,反应收率高、纯度好,反应条件温和,而且本申请的反应原料廉价、易得,能够大大降低反应成本,反应路线可控制在6步及以内,大大简化了反应路线并且提高了反应效率,生产周期明显缩短,并且本申请的方法易于放大,生产规模可达百克级别,能够实现规模化生产。The present application provides an intermediate and method for preparing pyrroloquinoline quinone. The reaction route for preparing pyrroloquinoline quinone with the intermediate of the present application is simple, the reaction yield is high, the purity is good, the reaction conditions are mild, and the reaction raw materials of the present application are cheap and easy to obtain, which can greatly reduce the reaction cost, and the reaction route can be controlled within 6 steps or less, which greatly simplifies the reaction route and improves the reaction efficiency, significantly shortens the production cycle, and the method of the present application is easy to scale up, and the production scale can reach the hundred-gram level, which can realize large-scale production.
具体地,本申请提供了下述技术方案:Specifically, this application provides the following technical solutions:
在本申请的第一方面,本申请提供如式I和式II所示的化合物,其结构式为:In the first aspect of the present application, the present application provides compounds as shown in Formula I and Formula II, whose structural formula is:
Figure PCTCN2022142378-appb-000001
Figure PCTCN2022142378-appb-000001
其中,R 1为C 1-C 3直链或支链烷基,R 2为硝基或氨基;R 3选自氢和C 1-C 3直链或支链烷基。 Wherein, R1 is a C1 - C3 straight chain or branched alkyl group, R2 is a nitro group or an amino group; and R3 is selected from hydrogen and a C1 - C3 straight chain or branched alkyl group.
进一步地,本申请所述化合物具有如下所示的结构:Furthermore, the compound described in the present application has the structure shown below:
Figure PCTCN2022142378-appb-000002
Figure PCTCN2022142378-appb-000002
其中,R 1、R 2和R 3如上文中所定义。 wherein R 1 , R 2 and R 3 are as defined above.
在本申请的一些实施方式中,R 1优选为甲基或乙基。 In some embodiments of the present application, R 1 is preferably methyl or ethyl.
在本申请的一些实施方式中,R 3优选为氢、甲基、乙基或丙基。 In some embodiments of the present application, R 3 is preferably hydrogen, methyl, ethyl or propyl.
在本申请的第二方面,本申请提供了式I化合物、式II化合物或式X化合物作为中间体在制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸(又名吡咯喹啉醌,PQQ或methoxatin)中的应用;In the second aspect of the present application, the present application provides the use of a compound of formula I, a compound of formula II or a compound of formula X as an intermediate in the preparation of 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid (also known as pyrroloquinoline quinone, PQQ or methoxatin);
Figure PCTCN2022142378-appb-000003
Figure PCTCN2022142378-appb-000003
其中,R 1、R 2和R 3如上文中所定义。 wherein R 1 , R 2 and R 3 are as defined above.
作为示例,上述第一方面能够所述的可作为制备吡咯喹啉醌的中间体化合物选自以下结构:As an example, the intermediate compound that can be used to prepare pyrroloquinoline quinone in the first aspect above is selected from the following structures:
3,4-二甲氧基-5-硝基苯胺;3,4-Dimethoxy-5-nitroaniline;
3,4-二乙氧基-5-硝基苯胺;3,4-diethoxy-5-nitroaniline;
(Z)-2-(2-(3,4-二甲氧基-5-硝基苯基)肼基)丙酸乙酯(化合物I-1-1,R 1为甲基,R 2为硝基); (Z)-2-(2-(3,4-dimethoxy-5-nitrophenyl)hydrazine)propanoic acid ethyl ester (compound I-1-1, R 1 is methyl, R 2 is nitro);
(Z)-2-(2-(3,4-二乙氧基-5-硝基苯基)肼基)丙酸乙酯(化合物I-1-2,R 1为乙基,R 2为硝基); (Z)-2-(2-(3,4-diethoxy-5-nitrophenyl)hydrazine)propanoic acid ethyl ester (compound I-1-2, R 1 is ethyl, R 2 is nitro);
(Z)-2-(2-(3-氨基-4,5-二甲氧基苯基)肼基)丙酸乙酯(化合物I-2-1,R 1为甲基,R 2为氨基); (Z)-2-(2-(3-amino-4,5-dimethoxyphenyl)hydrazine)propanoic acid ethyl ester (compound I-2-1, R 1 is methyl, R 2 is amino);
(Z)-2-(2-(3-氨基-4,5-二乙氧基苯基)肼基)丙酸乙酯(化合物I-2-2,R 1为甲基,R 2为氨基); (Z)-2-(2-(3-amino-4,5-diethoxyphenyl)hydrazine)propanoic acid ethyl ester (compound I-2-2, R 1 is methyl, R 2 is amino);
(Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二羧酸(化合物II-1-1,R 1为甲基,R 3为氢); (Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid (compound II-1-1, R 1 is methyl, R 3 is hydrogen);
(Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二甲酸二甲酯(化合物II-1-2,R 1为甲基,R 3为甲基); (Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid dimethyl ester (compound II-1-2, R 1 is methyl, R 3 is methyl);
(Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二羧酸二乙酯(化合物II-1-3,R 1为甲基,R 3为乙基); (Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid diethyl ester (Compound II-1-3, R 1 is methyl, R 3 is ethyl);
(Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二羧酸二丙酯(化合物II-1-4,R 1为甲基,R 3为丙基); (Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid dipropyl ester (Compound II-1-4, R 1 is methyl, R 3 is propyl);
(Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二羧酸(化合物II-2-1,R 1为乙基,R 3为氢); (Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)quinoline-2,4-dicarboxylic acid (compound II-2-1, R 1 is ethyl, R 3 is hydrogen);
(Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二甲酸二甲酯(化合物II-2-2,R 1为乙基,R 3为甲基); (Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)quinoline-2,4-dicarboxylic acid dimethyl ester (compound II-2-2, R 1 is ethyl, R 3 is methyl);
(Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二甲酸二乙酯(化合物 II-2-3,R 1为乙基,R 3为乙基); (Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)quinoline-2,4-dicarboxylic acid diethyl ester (compound II-2-3, R 1 is ethyl, R 3 is ethyl);
(Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二甲酸二丙酯(化合物II-2-4,R 1为乙基,R 3为丙基)。 (Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)quinoline-2,4-dicarboxylic acid dipropyl ester (Compound II-2-4, R 1 is ethyl, R 3 is propyl).
特别是,以上述化合物制备吡咯喹啉醌时,反应收率高、纯度好,且反应简洁,条件温和,反应路线仅6步即可实现,大大简化了反应方法、提高了反应效率,并且反应原料廉价、易得,大大降低了反应的成本,以上述中间体化合物制备吡咯喹啉醌,易于放大,能够进行规模化生产。In particular, when the above-mentioned compounds are used to prepare pyrroloquinoline quinone, the reaction yield is high and the purity is good. The reaction is simple and the conditions are mild. The reaction route can be achieved in only 6 steps, which greatly simplifies the reaction method and improves the reaction efficiency. In addition, the reaction raw materials are cheap and easily available, which greatly reduces the cost of the reaction. The above-mentioned intermediate compounds are used to prepare pyrroloquinoline quinone, which is easy to scale up and can be produced on a large scale.
在本申请的第三方面,本申请提供了一种制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸的方法,所述方法包括:式II化合物通过Fischer吲哚合成法制备式III化合物,然后水解式III化合物制备式IV化合物,最后氧化式IV化合物制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸;In the third aspect of the present application, the present application provides a method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the method comprising: preparing a compound of formula III from a compound of formula II by Fischer indole synthesis, then hydrolyzing the compound of formula III to prepare a compound of formula IV, and finally oxidizing the compound of formula IV to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid;
Figure PCTCN2022142378-appb-000004
Figure PCTCN2022142378-appb-000004
其中,R 1、R 3同上文中所定义; Wherein, R 1 and R 3 are as defined above;
优选地,R 1为甲基或乙基,R 3选自氢、甲基、乙基和丙基。 Preferably, R1 is methyl or ethyl, and R3 is selected from hydrogen, methyl, ethyl and propyl.
在本申请的一种实施方式中,式II化合物可由式I-2化合物与式V化合物在Lewis酸催化作用下制备得到,In one embodiment of the present application, the compound of formula II can be prepared by reacting a compound of formula I-2 with a compound of formula V under the catalysis of Lewis acid.
Figure PCTCN2022142378-appb-000005
Figure PCTCN2022142378-appb-000005
其中,R 1、R 3同上文中所定义。 Wherein, R 1 and R 3 are as defined above.
优选地,R 1为甲基或乙基,R 3选自氢、甲基、乙基和丙基。 Preferably, R1 is methyl or ethyl, and R3 is selected from hydrogen, methyl, ethyl and propyl.
在本申请的第四方面,本申请提供了一种制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸的方法,所述方法包括:式I-2化合物与式V化合物在Lewis酸催化作用下制备式II化合物,然后式II化合物通过Fischer吲哚合成法制备式III化合物,之后水解式III化合 物制备式IV化合物,最后氧化式IV化合物制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸;In the fourth aspect of the present application, the present application provides a method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the method comprising: preparing a compound of formula II from a compound of formula I-2 and a compound of formula V under Lewis acid catalysis, then preparing a compound of formula III from the compound of formula II by Fischer indole synthesis, then hydrolyzing the compound of formula III to prepare a compound of formula IV, and finally oxidizing the compound of formula IV to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid;
Figure PCTCN2022142378-appb-000006
Figure PCTCN2022142378-appb-000006
其中,R 1、R 3同上文中所定义。 Wherein, R 1 and R 3 are as defined above.
优选地,R 1为甲基或乙基,R 3选自氢、甲基、乙基和丙基。 Preferably, R1 is methyl or ethyl, and R3 is selected from hydrogen, methyl, ethyl and propyl.
在本申请的一种实施方式中,式I-2化合物可通过还原式I-1化合物制备得到。In one embodiment of the present application, the compound of formula I-2 can be prepared by reducing the compound of formula I-1.
在本申请的第五方面,本申请提供了一种制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸的方法,所述方法包括:还原式I-1化合物制备式I-2化合物,然后式I-2化合物与式V化合物在Lewis酸催化作用下制备式II化合物,之后式II化合物通过Fischer吲哚合成法制备式III化合物,然后水解式III化合物制备式IV化合物,最后氧化式IV化合物制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸;In the fifth aspect of the present application, the present application provides a method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the method comprising: reducing a compound of formula I-1 to prepare a compound of formula I-2, then reacting the compound of formula I-2 with a compound of formula V under Lewis acid catalysis to prepare a compound of formula II, then reacting the compound of formula II to prepare a compound of formula III by Fischer indole synthesis, then hydrolyzing the compound of formula III to prepare a compound of formula IV, and finally oxidizing the compound of formula IV to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid;
Figure PCTCN2022142378-appb-000007
Figure PCTCN2022142378-appb-000007
其中,R 1、R 3同上文中所定义。 Wherein, R 1 and R 3 are as defined above.
优选地,R 1为甲基或乙基,R 3选自氢、甲基、乙基和丙基。 Preferably, R1 is methyl or ethyl, and R3 is selected from hydrogen, methyl, ethyl and propyl.
在本申请的一种实施方式中,式I-1化合物可由3,4-二烷氧基-5-硝基苯胺(比如式X化合物)进行重氮化后与2-甲基乙酰乙酸乙酯缩合制备,其中,R 1如上文中所定义。 In one embodiment of the present application, the compound of formula I-1 can be prepared by diazotizing 3,4-dialkoxy-5-nitroaniline (such as the compound of formula X) and condensing it with ethyl 2-methylacetoacetate, wherein R 1 is as defined above.
在本申请的第六方面,本申请提供了一种制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸的方法,所述方法包括:3,4-二烷氧基-5-硝基苯胺(式X化合物)进行重氮化后与2-甲基乙酰乙酸乙酯缩合制备式I-1化合物,还原式I-1化合物制备式I-2化合物,然后式I-2化合物与式V化合物在Lewis酸催化作用下制备式II化合物,之后式II化合物通过Fischer吲哚合成法制备式III化合物,然后水解式III化合物制备式IV化合物,最后氧化式IV化合物制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸;In the sixth aspect of the present application, the present application provides a method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the method comprising: 3,4-dialkoxy-5-nitroaniline (compound of formula X) is diazotized and then condensed with ethyl 2-methylacetoacetate to prepare a compound of formula I-1, the compound of formula I-1 is reduced to prepare a compound of formula I-2, and then the compound of formula I-2 and the compound of formula V are catalyzed by Lewis acid to prepare a compound of formula II, and then the compound of formula II is prepared by Fischer indole synthesis to prepare a compound of formula III, and then the compound of formula III is hydrolyzed to prepare a compound of formula IV, and finally the compound of formula IV is oxidized to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid;
Figure PCTCN2022142378-appb-000008
Figure PCTCN2022142378-appb-000008
其中,R 1、R 3同上文中所定义。 Wherein, R 1 and R 3 are as defined above.
优选地,R 1为甲基或乙基,R 3选自氢、甲基、乙基和丙基。 Preferably, R1 is methyl or ethyl, and R3 is selected from hydrogen, methyl, ethyl and propyl.
在本申请的一种实施方式中,所述3,4-二烷氧基-5-硝基苯胺(式X化合物)可以3,4-二烷氧基-5-硝基苯甲酸或3,4-二烷氧基-5-硝基苯甲酰胺为原料制备,其中,R 1如上文中所定义。 In one embodiment of the present application, the 3,4-dialkoxy-5-nitroaniline (compound of formula X) can be prepared using 3,4-dialkoxy-5-nitrobenzoic acid or 3,4-dialkoxy-5-nitrobenzamide as a raw material, wherein R 1 is as defined above.
在本申请的一种实施方式中,上述制备方法中的最后一步氧化,即氧化式IV化合物制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸的步骤可以直接氧化或者包括:将式IV化合物与质子酸反应制备2-(乙氧羰基)-4,5-二羟基-1H-吡咯并[2,3-f]喹啉-7,9-二羧酸,然后在氧化剂作用下氧化2-(乙氧羰基)-4,5-二羟基-1H-吡咯并[2,3-f]喹啉-7,9-二羧酸制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸。In one embodiment of the present application, the last oxidation step in the above preparation method, i.e., the step of oxidizing the compound of formula IV to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, can be directly oxidized or include: reacting the compound of formula IV with a protonic acid to prepare 2-(ethoxycarbonyl)-4,5-dihydroxy-1H-pyrrolo[2,3-f]quinoline-7,9-dicarboxylic acid, and then oxidizing 2-(ethoxycarbonyl)-4,5-dihydroxy-1H-pyrrolo[2,3-f]quinoline-7,9-dicarboxylic acid under the action of an oxidant to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid.
在本申请的实施方式中,所述质子酸可以为氢溴酸、氢碘酸或氢氯酸。所述氧化剂可以为双氧水、浓硫酸、浓硝酸或臭氧。In an embodiment of the present application, the protonic acid may be hydrobromic acid, hydroiodic acid or hydrochloric acid. The oxidant may be hydrogen peroxide, concentrated sulfuric acid, concentrated nitric acid or ozone.
相较于现有技术,本申请的优势在于:以本申请所述的中间体制备吡咯喹啉醌时,反应 路线简单,反应收率高(单步收率均在75%以上,总收率显著提高)、纯度好,反应条件温和,而且本申请的反应原料廉价、易得,能够大大降低反应成本,反应路线可控制在6步及以内,大大简化了反应路线并且提高了反应效率,缩短了反应周期,本申请的方法易于放大,生产规模可达百克级别,能够规模化生产。Compared with the prior art, the advantages of the present application are: when the intermediate described in the present application is used to prepare pyrroloquinoline quinone, the reaction route is simple, the reaction yield is high (the single-step yield is above 75%, and the total yield is significantly improved), the purity is good, the reaction conditions are mild, and the reaction raw materials of the present application are cheap and easy to obtain, which can greatly reduce the reaction cost. The reaction route can be controlled within 6 steps or less, which greatly simplifies the reaction route and improves the reaction efficiency, shortens the reaction cycle, and the method of the present application is easy to scale up, and the production scale can reach the hundred-gram level, which can be mass-produced.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
构成本申请的一部分的说明书附图用来提供对本申请的进一步理解,本申请的示意性实施例及其说明用于解释本申请,并不构成对本申请的不当限定。以下,结合附图来详细说明本申请的实施方案,其中:The drawings constituting part of the present application are used to provide a further understanding of the present application. The illustrative embodiments of the present application and their descriptions are used to explain the present application and do not constitute an improper limitation on the present application. The implementation scheme of the present application is described in detail below in conjunction with the drawings, wherein:
图1为式I-1的示例化合物的氢谱。FIG1 is a hydrogen spectrum of an exemplary compound of formula I-1.
图2为式I-1的示例化合物的碳谱。FIG2 is a carbon spectrum of an exemplary compound of formula I-1.
图3为式I-2的示例化合物的氢谱。FIG3 is a hydrogen spectrum of an exemplary compound of formula I-2.
图4为式I-2的示例化合物的碳谱。FIG4 is a carbon spectrum of an exemplary compound of formula I-2.
具体实施方式Detailed ways
下面结合具体实施例,进一步阐述本申请。应理解,这些实施例仅用于说明本申请而不用于限制本申请的范围。下列实施例中未注明具体条件的实验方法,通常按照常规条件或按照制造厂商所建议的条件。The present application is further described below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present application and are not intended to limit the scope of the present application. The experimental methods in the following examples without specifying specific conditions are usually carried out under conventional conditions or according to the conditions recommended by the manufacturer.
除非另行定义,文中所使用的所有专业与科学用语与本领域熟练人员所熟悉的意义相同。本申请所使用的试剂或原料均可通过常规途径购买获得,如无特殊说明,本申请所使用的试剂或原料均按照本领域常规方式使用或者按照产品说明书使用。此外,任何与所记载内容相似或均等的方法及材料皆可应用于本申请方法中。文中所述的较佳实施方法与材料仅作示范之用。Unless otherwise defined, all professional and scientific terms used herein have the same meanings as those familiar to those skilled in the art. The reagents or raw materials used in this application can be purchased through conventional channels. Unless otherwise specified, the reagents or raw materials used in this application are used in a conventional manner in the art or in accordance with the product instructions. In addition, any method and material similar to or equivalent to the content described herein can be applied to the method of this application. The preferred implementation methods and materials described in the text are for demonstration purposes only.
本申请提供了式I化合物和式II化合物及其制备方法,以及提供了以式I化合物、式II化合物和/或式X化合物为中间体制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸的方法。The present application provides compounds of formula I and formula II and methods for preparing the same, as well as a method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid using compounds of formula I, formula II and/or formula X as intermediates.
在本申请的一些实施方式中,以式II为中间体制备吡咯喹啉醌的方法可按照以下反应路线进行:In some embodiments of the present application, the method for preparing pyrroloquinoline quinone using formula II as an intermediate can be carried out according to the following reaction scheme:
Figure PCTCN2022142378-appb-000009
Figure PCTCN2022142378-appb-000009
其中,R 1为C 1-C 3直链或支链烷基,R 3选自氢和C 1-C 3直链或支链烷基。 Wherein, R1 is a C1 - C3 straight chain or branched chain alkyl group, and R3 is selected from hydrogen and a C1 - C3 straight chain or branched chain alkyl group.
在本申请的较为优选的实施方式中,R 1为甲基或乙基,R 3为甲基、乙基或丙基。 In a more preferred embodiment of the present application, R1 is a methyl group or an ethyl group, and R3 is a methyl group, an ethyl group or a propyl group.
在本申请的反应路线中,以式II化合物作为中间体进行Fischer吲哚合成时,该结构中的喹啉能够起到占位作用从而提高吲哚合成时的选择性,避免了不必要副反应物质的产生,大大提升了合成效率和收率并且减少了后续的繁杂的纯化工作。In the reaction route of the present application, when the Fischer indole synthesis is carried out using the compound of formula II as an intermediate, the quinoline in the structure can play a placeholder role to improve the selectivity of indole synthesis, avoid the generation of unnecessary side reaction substances, greatly improve the synthesis efficiency and yield, and reduce the subsequent complicated purification work.
在本申请的一些实施方式中,以式I为中间体(式I-2)制备吡咯喹啉醌的方法可按照以下反应路线进行:In some embodiments of the present application, the method for preparing pyrroloquinoline quinone using Formula I as an intermediate (Formula I-2) can be carried out according to the following reaction route:
Figure PCTCN2022142378-appb-000010
Figure PCTCN2022142378-appb-000010
其中,R 1为C 1-C 3直链或支链烷基,R 2为氨基,R 3选自氢和C 1-C 3直链或支链烷基。 Wherein, R1 is a C1 - C3 straight chain or branched chain alkyl group, R2 is an amino group, and R3 is selected from hydrogen and a C1 - C3 straight chain or branched chain alkyl group.
在本申请的较为优选的实施方式中,R 1为甲基或乙基,R 3为甲基、乙基或丙基。 In a more preferred embodiment of the present application, R1 is a methyl group or an ethyl group, and R3 is a methyl group, an ethyl group or a propyl group.
其中,进一步地,所述反应路线可以为:Wherein, further, the reaction route can be:
Figure PCTCN2022142378-appb-000011
Figure PCTCN2022142378-appb-000011
其中,R 1为C 1-C 3直链或支链烷基,R 3选自氢和C 1-C 3直链或支链烷基。 Wherein, R1 is a C1 - C3 straight chain or branched chain alkyl group, and R3 is selected from hydrogen and a C1 - C3 straight chain or branched chain alkyl group.
在本申请的较为优选的实施方式中,R 1为甲基或乙基,R 3为甲基、乙基或丙基。 In a more preferred embodiment of the present application, R1 is a methyl group or an ethyl group, and R3 is a methyl group, an ethyl group or a propyl group.
本申请的反应路线中,以式I化合物作为中间体在制备吡咯喹啉醌时首先通过合成喹啉结构,然后再进行Fischer吲哚合成,通过喹啉占位提高吲哚合成的选择性,避免了不必要副反应物质的产生,大大提升了合成效率和收率并且减少了后续的繁杂的纯化工作。In the reaction route of the present application, when preparing pyrroloquinoline quinone using the compound of formula I as an intermediate, the quinoline structure is first synthesized, and then the Fischer indole synthesis is performed. The selectivity of the indole synthesis is improved by the quinoline occupancy, the generation of unnecessary side reaction substances is avoided, the synthesis efficiency and yield are greatly improved, and the subsequent complicated purification work is reduced.
在本申请的一些实施方式中,以3,4-二烷氧基-5硝基苯胺化合物(式X化合物)制备吡咯喹啉醌的方法可按照以下反应路线进行:In some embodiments of the present application, the method for preparing pyrroloquinoline quinone using a 3,4-dialkoxy-5-nitroaniline compound (compound of formula X) can be carried out according to the following reaction route:
Figure PCTCN2022142378-appb-000012
Figure PCTCN2022142378-appb-000012
其中,R 1为C 1-C 3直链或支链烷基,R 3选自氢和C 1-C 3直链或支链烷基。 Wherein, R1 is a C1 - C3 straight chain or branched chain alkyl group, and R3 is selected from hydrogen and a C1 - C3 straight chain or branched chain alkyl group.
在本申请的较为优选的实施方式中,R 1为甲基或乙基,R 3为甲基、乙基或丙基。 In a more preferred embodiment of the present application, R1 is a methyl group or an ethyl group, and R3 is a methyl group, an ethyl group or a propyl group.
在本申请的反应路线中,以3,4-二烷氧基-5硝基苯胺化合物(式X化合物)作为中间体在制备吡咯喹啉醌时首先通过合成喹啉结构,然后再进行Fischer吲哚合成,通过喹啉占位提高吲哚合成的选择性,避免了不必要副反应物质的产生,大大提升了合成效率和收率并且减少了 后续的繁杂的纯化工作。In the reaction route of the present application, 3,4-dialkoxy-5-nitroaniline compound (compound of formula X) is used as an intermediate to prepare pyrroloquinoline quinone by first synthesizing the quinoline structure and then performing the Fischer indole synthesis. The selectivity of the indole synthesis is improved by quinoline occupation, the generation of unnecessary side reaction substances is avoided, the synthesis efficiency and yield are greatly improved, and the subsequent complicated purification work is reduced.
在本申请的一些实施方式中,上述多种反应中的最后一步均为氧化反应,所述氧化反应可一步进行,也可按照以下反应路线进行:In some embodiments of the present application, the last step of the above-mentioned multiple reactions is an oxidation reaction, which can be carried out in one step or according to the following reaction route:
Figure PCTCN2022142378-appb-000013
Figure PCTCN2022142378-appb-000013
比如,在一个较为具体的实施方式中,所述吡咯喹啉醌的制备方法包括:For example, in a more specific embodiment, the preparation method of pyrroloquinoline quinone includes:
(1)化合物3,4-二烷氧基-5-硝基苯胺(式X化合物)与亚硝酸钠溶液在酸性条件下重氮化,再与2-甲基乙酰乙酸乙酯在碱性条件下缩合形成式I-1化合物;(1) diazotizing the compound 3,4-dialkoxy-5-nitroaniline (compound of formula X) with sodium nitrite solution under acidic conditions, and then condensing with ethyl 2-methylacetoacetate under alkaline conditions to form a compound of formula I-1;
在本申请的一些实施方式中,式X化合物与2-甲基乙酰乙酸乙酯的摩尔比为1:1-5。In some embodiments of the present application, the molar ratio of the compound of formula X to ethyl 2-methylacetoacetate is 1:1-5.
在本申请的一些实施方式中,步骤(1)的反应阶段温度控制在-10℃-0℃。In some embodiments of the present application, the temperature of the reaction stage of step (1) is controlled at -10°C to 0°C.
比如,在本申请的一些实施方式中,步骤(1)包括:以无水乙醇为溶剂和式X化合物搅拌混合,将反应体系温度降温至-10℃-0℃,加入酸(比如浓盐酸或浓硫酸),保持反应体系温度在-10℃-0℃,加入亚硝酸钠,在-10℃-0℃搅拌,加入2-甲基乙酰乙酸乙酯,并加入乙酸钠,-10℃-0℃保温搅拌反应。For example, in some embodiments of the present application, step (1) comprises: stirring and mixing anhydrous ethanol as a solvent and a compound of formula X, cooling the reaction system to -10°C-0°C, adding an acid (such as concentrated hydrochloric acid or concentrated sulfuric acid), maintaining the reaction system temperature at -10°C-0°C, adding sodium nitrite, stirring at -10°C-0°C, adding ethyl 2-methylacetoacetate, and adding sodium acetate, and stirring and reacting at -10°C-0°C.
(2)式I-1化合物在还原剂作用下发生还原反应制得式I-2化合物;(2) the compound of formula I-1 undergoes a reduction reaction under the action of a reducing agent to obtain a compound of formula I-2;
在本申请的一些实施方式中,式I-1化合物与还原剂比如铁粉在醋酸溶液中进行还原反应,反应温度控制在60-80℃。In some embodiments of the present application, the compound of formula I-1 is subjected to a reduction reaction with a reducing agent such as iron powder in an acetic acid solution, and the reaction temperature is controlled at 60-80°C.
(3)化合物式I-2与式V化合物在Lewis酸催化作用下在氧气氛围下发生反应,制得式II化合物;(3) The compound of formula I-2 reacts with the compound of formula V under the catalysis of Lewis acid in an oxygen atmosphere to obtain a compound of formula II;
在本申请的一些实施方式中,化合物式I-2与式V化合物的摩尔比为1:1-5。In some embodiments of the present application, the molar ratio of the compound of formula I-2 to the compound of formula V is 1:1-5.
比如,在本申请的一些实施方式中,步骤(3)包括:化合物式I-2和溶剂(比如二氯甲烷)搅拌均匀后,再加入式V化合物和Lewis酸(比如氯化锌),室温下搅拌反应。For example, in some embodiments of the present application, step (3) comprises: after the compound of formula I-2 and a solvent (such as dichloromethane) are stirred evenly, a compound of formula V and a Lewis acid (such as zinc chloride) are added, and the reaction is stirred at room temperature.
(4)式II化合物通过Fischer吲哚合成法制得式III化合物;(4) The compound of formula II is prepared by Fischer indole synthesis to obtain the compound of formula III;
在本申请的一些实施方式中,反应温度控制在30-55℃。In some embodiments of the present application, the reaction temperature is controlled at 30-55°C.
比如,在本申请的一些实施方式中,步骤(4)包括:将过量硫酸与化合物式II搅拌均匀,将反应体系升温至30-55℃搅拌反应。For example, in some embodiments of the present application, step (4) comprises: uniformly stirring excess sulfuric acid and compound II, heating the reaction system to 30-55° C. and stirring the reaction.
(5)式III化合物发生酯水解反应,制得式IV化合物;(5) the compound of formula III undergoes ester hydrolysis reaction to obtain the compound of formula IV;
在本申请的一些实施方式中,酯水解反应在碱性环境中发生,温度控制在80-90℃。In some embodiments of the present application, the ester hydrolysis reaction occurs in an alkaline environment and the temperature is controlled at 80-90°C.
(6)氧化式IV化合物制得PQQ,或者,由式IV化合物制备得到中间体F后氧化得到PQQ;(6) oxidizing the compound of formula IV to obtain PQQ, or, preparing intermediate F from the compound of formula IV and then oxidizing it to obtain PQQ;
比如,中间体E可通过与质子酸反应制备得到中间体F,质子酸可以为氢溴酸、氢氯酸或氢碘酸,优选为氢碘酸;比如,所述氧化可采用氧化剂,所述氧化剂可以选自双氧水、浓硫酸、浓硝酸和臭氧中的一种或多种,优选为双氧水。For example, intermediate E can be prepared by reacting with a protonic acid to obtain intermediate F, and the protonic acid can be hydrobromic acid, hydrochloric acid or hydroiodic acid, preferably hydroiodic acid; for example, the oxidation can use an oxidant, and the oxidant can be selected from one or more of hydrogen peroxide, concentrated sulfuric acid, concentrated nitric acid and ozone, preferably hydrogen peroxide.
应当得以肯定的是,本申请最为重要的部分在于中间体的设计、以及以中间体获得目标产物PQQ的实验路线的设计。根据本申请披露的中间体以及以所述中间体设计的路线,以此为基础调试或改变反应环境、反应参数以进一步优化反应的操作均属于本领域技术人员的基本操作技能,并不能实质上构成对本申请所述技术方案的改进,均应属于本申请的保护范围中的一部分。It should be affirmed that the most important part of this application is the design of the intermediates and the design of the experimental route for obtaining the target product PQQ using the intermediates. Based on the intermediates disclosed in this application and the routes designed based on the intermediates, the operations of debugging or changing the reaction environment and reaction parameters to further optimize the reaction are all basic operating skills of those skilled in the art, and cannot substantially constitute an improvement on the technical solution described in this application, and should all be part of the protection scope of this application.
具体地,结合上述反应路线,本申请给出以下制备示例。Specifically, in combination with the above reaction route, the present application provides the following preparation examples.
如无特殊说明,本申请实验中所述室温是指20-25℃。Unless otherwise specified, the room temperature in the experiments of this application refers to 20-25°C.
其中,起始反应物3,4-二甲氧基-5-硝基苯胺可以3,4-二甲氧基-5-硝基苯甲酸或3,4-二甲氧基-5-硝基苯甲酰胺为原料制备得到。比如,3,4-二甲氧基-5-硝基苯胺可按照美国专利US5236952中的方法制备得到,专利中的相关内容通过引用合并入本申请。或者,作为示例,3,4-二甲氧基-5-硝基苯胺可按照下述方法制备得到:Among them, the starting reactant 3,4-dimethoxy-5-nitroaniline can be prepared using 3,4-dimethoxy-5-nitrobenzoic acid or 3,4-dimethoxy-5-nitrobenzamide as raw materials. For example, 3,4-dimethoxy-5-nitroaniline can be prepared according to the method in U.S. Pat. No. 5,236,952, and the relevant contents of the patent are incorporated into this application by reference. Alternatively, as an example, 3,4-dimethoxy-5-nitroaniline can be prepared according to the following method:
将甲苯908g、亚硫酰氯180g和3,4-二甲氧基-5-硝基苯甲酸227g投入2000mL反应瓶中,升温至80℃,于70-80℃保温反应8h。反应完毕,减压蒸馏甲苯至85℃,剩余物稍冷却至50℃,用100g丙酮稀释后,将剩余物缓慢反加至预先冷却至5℃以下的25%氨水1000g中。反加完毕,析出固体料为3,4-二甲氧基-5-硝基苯甲酰胺。抽滤,得3,4-二甲氧基-5-硝基苯甲酰胺湿品490g。908g of toluene, 180g of thionyl chloride and 227g of 3,4-dimethoxy-5-nitrobenzoic acid were put into a 2000mL reaction bottle, heated to 80°C, and kept at 70-80°C for 8h. After the reaction was completed, toluene was distilled under reduced pressure to 85°C, the residue was slightly cooled to 50°C, diluted with 100g of acetone, and the residue was slowly added back to 1000g of 25% ammonia water pre-cooled to below 5°C. After the addition was completed, the solid material precipitated was 3,4-dimethoxy-5-nitrobenzamide. Filtered to obtain 490g of 3,4-dimethoxy-5-nitrobenzamide wet product.
向另一3000mL反应瓶中投入10%次氯酸钠950g和10%碳酸钠1060g,冷却至20℃以下。向反应瓶中投入3,4-二甲氧基-5-硝基苯甲酰胺湿品490g,于15-20℃搅拌反应3h。反应完毕,于1h内升温至70℃,于70-75℃搅拌反应3h。反应完毕,冷却至5℃以下,搅拌结晶3h,抽滤得3,4-二甲氧基-5-硝基苯胺湿品390g,于烘箱内90℃烘干得3,4-二甲氧基-5-硝基苯胺干品168.3g。摩尔收率:85%,HPLC纯度99%。Add 950g of 10% sodium hypochlorite and 1060g of 10% sodium carbonate to another 3000mL reaction bottle and cool to below 20°C. Add 490g of wet 3,4-dimethoxy-5-nitrobenzamide to the reaction bottle and stir at 15-20°C for 3h. After the reaction is complete, heat to 70°C within 1h and stir at 70-75°C for 3h. After the reaction is complete, cool to below 5°C, stir and crystallize for 3h, filter to obtain 390g of wet 3,4-dimethoxy-5-nitroaniline, and dry in an oven at 90°C to obtain 168.3g of dry 3,4-dimethoxy-5-nitroaniline. Molar yield: 85%, HPLC purity 99%.
根据上述方法,以3,4-二乙氧基-5-硝基苯甲酸为原料替换3,4-二甲氧基-5-硝基苯甲酸,可制备得到3,4-二乙氧基-5-硝基苯胺。According to the above method, 3,4-diethoxy-5-nitrobenzoic acid is used as a raw material to replace 3,4-dimethoxy-5-nitrobenzoic acid to prepare 3,4-diethoxy-5-nitroaniline.
进行多次上述投料反应以积累3,4-二甲氧基-5-硝基苯胺物料和3,4-二乙氧基-5-硝基苯胺物 料用于目标产物的制备。The above-mentioned charging reaction is carried out multiple times to accumulate 3,4-dimethoxy-5-nitroaniline material and 3,4-diethoxy-5-nitroaniline material for the preparation of the target product.
下述实施例中示意了本申请所述中间体的制备过程以及在一些条件下的以本申请所述中间体制备PQQ的具体过程,下述实施例是制备百克级别产品时的示例,为了积累足够的物料进行每一步反应,下述示例在实际操作中会进行多次投料反应,每次投料过程均相同,以下各制备例仅示意一次投料制备过程。The following examples illustrate the preparation process of the intermediates described in the present application and the specific process of preparing PQQ using the intermediates described in the present application under certain conditions. The following examples are examples of preparing products at the 100-gram level. In order to accumulate sufficient materials for each step of the reaction, the following examples will perform multiple feeding reactions in actual operations, and each feeding process is the same. The following preparation examples only illustrate a single feeding preparation process.
实施例1式I化合物的制备Example 1 Preparation of Compounds of Formula I
制备例1:(Z)-2-(2-(3,4-二甲氧基-5-硝基苯基)肼)丙酸乙酯(化合物I-1-1)的制备Preparation Example 1: Preparation of (Z)-2-(2-(3,4-dimethoxy-5-nitrophenyl)hydrazine)propionic acid ethyl ester (Compound I-1-1)
向反应瓶中投入无水乙醇500g和3,4-二甲氧基-5硝基苯胺198g搅拌混合均匀。将反应体系温度降温至-10℃,将365g浓盐酸滴入反应瓶,滴完后将反应体系降温至-10℃,开始快速滴加40%亚硝酸钠233g。滴加完毕,于-5℃搅拌1h。反应完毕,于-5℃向反应瓶中加入200g 2-甲基乙酰乙酸乙酯,投毕,于-5℃滴加30%乙酸钠1366.7g。滴加完毕,于-5℃-0℃保温搅拌反应4h。反应完毕,将反应体系升温至室温搅拌反应16h。反应完毕,抽滤,固体料水洗一次,干燥烘干得化合物I-1-1,产量280g,收率:89.9%,HPLC纯度97%,化合物式I-1-1的氢谱和碳谱分别如图1和图2所示。Add 500g of anhydrous ethanol and 198g of 3,4-dimethoxy-5-nitroaniline to the reaction bottle and stir to mix evenly. Cool the reaction system to -10°C, drip 365g of concentrated hydrochloric acid into the reaction bottle, cool the reaction system to -10°C after dripping, and start to quickly drip 233g of 40% sodium nitrite. After the dripping is completed, stir at -5°C for 1h. After the reaction is completed, add 200g of ethyl 2-methylacetoacetate to the reaction bottle at -5°C, and after the addition, drip 1366.7g of 30% sodium acetate at -5°C. After the dripping is completed, keep warm and stir at -5°C-0°C for 4h. After the reaction is completed, warm the reaction system to room temperature and stir for 16h. After the reaction is completed, filter, wash the solid material with water once, dry and dry to obtain compound I-1-1, with a yield of 280g, a yield of 89.9%, and an HPLC purity of 97%. The hydrogen spectrum and carbon spectrum of compound formula I-1-1 are shown in Figures 1 and 2, respectively.
制备例2:(Z)-2-(2-(3,4-二甲氧基-5-硝基苯基)肼)丙酸乙酯(化合物I-1-1)的制备Preparation Example 2: Preparation of (Z)-2-(2-(3,4-dimethoxy-5-nitrophenyl)hydrazine)propanoic acid ethyl ester (Compound I-1-1)
向反应瓶中投入无水乙醇500g和3,4-二甲氧基-5硝基苯胺198g搅拌混合均匀。将反应体系温度降温-10℃,将365g浓盐酸滴入反应瓶,滴完后将反应体系降温至-10℃,开始快速滴加40%亚硝酸钠233g,滴加温度控制在-5-0℃。滴加完毕,于-5-0℃以下搅拌1h。反应完毕,于0℃向反应瓶中加入200g 2-甲基乙酰乙酸乙酯,投毕,于-5-0℃滴加30%乙酸钠1366.7g。滴加完毕,于-5℃-0℃保温搅拌反应4h。反应完毕,将反应体系升温至20-25℃搅拌反应16h。反应完毕,抽滤,固体料水洗一次,干燥烘干得化合物I-1-1,产量268g,其核磁数据与制备例1制备得到的化合物基本一致。收率:86.2%,HPLC纯度98%。Add 500g of anhydrous ethanol and 198g of 3,4-dimethoxy-5-nitroaniline to the reaction bottle and stir to mix evenly. Cool the reaction system to -10℃, drip 365g of concentrated hydrochloric acid into the reaction bottle, cool the reaction system to -10℃ after dripping, and start to quickly drip 233g of 40% sodium nitrite, and control the dripping temperature at -5-0℃. After the dripping is completed, stir at -5-0℃ for 1h. After the reaction is completed, add 200g of ethyl 2-methylacetoacetate to the reaction bottle at 0℃, and after the addition, drip 1366.7g of 30% sodium acetate at -5-0℃. After the dripping is completed, keep warm and stir at -5℃-0℃ for 4h. After the reaction is completed, heat the reaction system to 20-25℃ and stir for 16h. After the reaction is completed, filter, wash the solid material with water once, and dry to obtain compound I-1-1, with a yield of 268g, and its NMR data is basically consistent with the compound prepared in Preparation Example 1. Yield: 86.2%, HPLC purity 98%.
制备例3:(Z)-2-(2-(3,4-二甲氧基-5-硝基苯基)肼)丙酸乙酯(化合物I-1-1)的制备Preparation Example 3: Preparation of (Z)-ethyl 2-(2-(3,4-dimethoxy-5-nitrophenyl)hydrazine)propanoate (Compound I-1-1)
向反应瓶中投入无水乙醇500g和3,4-二甲氧基-5硝基苯胺198g搅拌混合均匀。将反应体系温度降温至-10℃,将40%硫酸900g滴入反应瓶,滴完后将反应体系降温至-10℃,开始快速滴加40%亚硝酸钠233g,滴加温度控制在-10℃。滴加完毕,于-5-0℃搅拌1h。反应完毕,于-5-0℃向反应瓶中加入200g 2-甲基乙酰乙酸乙酯,投毕,于-5-0℃滴加30%碳酸氢钠2263g。滴加完毕,于-5-0℃保温搅拌反应4h。反应完毕,将反应体系升温至室温搅拌反应16h。反应完毕,抽 滤,固体料水洗一次,干燥烘干得化合物I-1-1,产量251.9g,其核磁数据与制备例1制备得到的化合物基本一致。收率:81%,HPLC纯度97.2%。Add 500g of anhydrous ethanol and 198g of 3,4-dimethoxy-5-nitroaniline to the reaction bottle and stir to mix evenly. Cool the reaction system to -10°C, drip 900g of 40% sulfuric acid into the reaction bottle, cool the reaction system to -10°C after dripping, and start to quickly drip 233g of 40% sodium nitrite, and control the dripping temperature at -10°C. After the dripping is completed, stir at -5-0°C for 1h. After the reaction is completed, add 200g of ethyl 2-methylacetoacetate to the reaction bottle at -5-0°C, and after the addition, drip 2263g of 30% sodium bicarbonate at -5-0°C. After the dripping is completed, keep warm and stir at -5-0°C for 4h. After the reaction is completed, heat the reaction system to room temperature and stir for 16h. After the reaction is completed, filter, wash the solid material with water once, and dry to obtain compound I-1-1, with a yield of 251.9g, and its nuclear magnetic resonance data is basically consistent with the compound prepared in Preparation Example 1. Yield: 81%, HPLC purity 97.2%.
将原料3,4-二甲氧基-5-硝基苯胺替换为3,4-二乙氧基-5-硝基苯胺,可根据制备例1-3中所述的方法制备得到(Z)-2-(2-(3,4-二乙氧基-5-硝基苯基)肼基)丙酸乙酯(化合物式I-1-2),摩尔收率在85%以上,HPLC纯度在95%以上。By replacing the raw material 3,4-dimethoxy-5-nitroaniline with 3,4-diethoxy-5-nitroaniline, (Z)-2-(2-(3,4-diethoxy-5-nitrophenyl)hydrazine)ethyl propionate (compound formula I-1-2) can be prepared according to the method described in Preparation Example 1-3, with a molar yield of more than 85% and an HPLC purity of more than 95%.
制备例4:(Z)-2-(2-(3-氨基-4,5-二甲氧基苯基)肼基)丙酸乙酯(化合物I-2-1)的制备Preparation Example 4: Preparation of (Z)-ethyl 2-(2-(3-amino-4,5-dimethoxyphenyl)hydrazine)propanoate (Compound I-2-1)
向反应瓶中投入168g铁粉和1000g的10%的醋酸,搅拌均匀,加热至80℃搅拌反应1h。稍冷缓慢加入311g化合物I-1-1(制备例1)。混合均匀后,升温至75-80℃搅拌反应6h,反应结束。冷却反应液至室温,用饱和碳酸钠溶液调pH至8-9,抽滤。固体物用热醇反复洗涤2次后,收集乙醇滤液,减压旋干乙醇,析出大量结晶,冷却至20℃,抽滤,收集固体并烘干,得到267g颗粒状结晶即化合物I-2-1。摩尔收率:95%,HPLC纯度:98.9%,化合物式I-2-1的氢谱和碳谱分别如图3和图4所示。Add 168g of iron powder and 1000g of 10% acetic acid to the reaction bottle, stir evenly, heat to 80°C and stir to react for 1h. Slightly cool and slowly add 311g of compound I-1-1 (Preparation Example 1). After mixing evenly, heat to 75-80°C and stir to react for 6h, and the reaction is completed. Cool the reaction solution to room temperature, adjust the pH to 8-9 with saturated sodium carbonate solution, and filter with suction. After the solid is washed repeatedly with hot alcohol twice, collect the ethanol filtrate, decompress and spin-dry the ethanol, precipitate a large amount of crystals, cool to 20°C, filter with suction, collect the solid and dry it to obtain 267g of granular crystals, namely compound I-2-1. Molar yield: 95%, HPLC purity: 98.9%, the hydrogen spectrum and carbon spectrum of compound formula I-2-1 are shown in Figures 3 and 4, respectively.
制备例5:(Z)-2-(2-(3-氨基-4,5-二甲氧基苯基)肼基)丙酸乙酯(化合物式I-2-1)的制备Preparation Example 5: Preparation of (Z)-ethyl 2-(2-(3-amino-4,5-dimethoxyphenyl)hydrazine)propanoate (Compound Formula I-2-1)
向反应瓶中投入168g铁粉和1000g的10%的醋酸,搅拌均匀,加热至80℃搅拌反应1h。稍冷,于50-65℃缓慢向反应瓶中投入311g化合物I-1-1(制备例1)。混合均匀后,升温至60-70℃搅拌反应6h,反应结束。冷却反应液至20-25℃,用饱和碳酸钠溶液调pH至8-9,抽滤。固体物用热乙醇反复洗涤2次后,收集乙醇滤液,减压旋干乙醇,析出大量结晶,冷却至20℃,抽滤,收集固体并烘干,得到250g颗粒状结晶即化合物I-2-1,其核磁数据与制备例4制备得到的化合物基本一致。摩尔收率:89%,HPLC纯度:98%。Add 168g of iron powder and 1000g of 10% acetic acid to the reaction bottle, stir evenly, heat to 80°C and stir to react for 1h. Cool slightly, slowly add 311g of compound I-1-1 (Preparation Example 1) to the reaction bottle at 50-65°C. After mixing evenly, heat to 60-70°C and stir to react for 6h, and the reaction is completed. Cool the reaction solution to 20-25°C, adjust the pH to 8-9 with saturated sodium carbonate solution, and filter. After the solid is washed repeatedly with hot ethanol twice, collect the ethanol filtrate, decompress and spin-dry the ethanol, precipitate a large amount of crystals, cool to 20°C, filter, collect the solid and dry it to obtain 250g of granular crystals, namely compound I-2-1, whose nuclear magnetic resonance data is basically consistent with the compound prepared in Preparation Example 4. Molar yield: 89%, HPLC purity: 98%.
制备例6:(Z)-2-(2-(3-氨基-4,5-二甲氧基苯基)肼基)丙酸乙酯(化合物I-2-1)的制备Preparation Example 6: Preparation of (Z)-ethyl 2-(2-(3-amino-4,5-dimethoxyphenyl)hydrazine)propanoate (Compound I-2-1)
向反应瓶中投入168g铁粉、500g乙醇和500g的20%的醋酸,搅拌均匀,加热至80℃搅拌反应1h。稍冷缓慢加入311g化合物I-1-1(制备例1)。混合均匀后,升温至75-80℃搅拌反应6h,反应结束。冷却反应液至室温,用饱和碳酸钠溶液调pH至8-9,抽滤。固体物用热醇反复洗涤2次后,收集乙醇滤液,减压旋干乙醇,析出大量结晶,冷却至20℃,抽滤,收集固体并烘干,得到258.5g颗粒状结晶即化合物式I-2-1,其核磁数据与制备例4制备得到的化合物基本一致。摩尔收率:92%,HPLC纯度:99%。Add 168g iron powder, 500g ethanol and 500g of 20% acetic acid into the reaction bottle, stir evenly, heat to 80℃ and stir for 1h. Slightly cool and slowly add 311g of compound I-1-1 (Preparation Example 1). After mixing evenly, heat to 75-80℃ and stir for 6h, and the reaction is completed. Cool the reaction solution to room temperature, adjust the pH to 8-9 with saturated sodium carbonate solution, and filter. After the solid is washed repeatedly with hot alcohol twice, collect the ethanol filtrate, decompress and spin-dry the ethanol, precipitate a large amount of crystals, cool to 20℃, filter, collect the solid and dry it to obtain 258.5g of granular crystals, namely compound formula I-2-1, whose nuclear magnetic resonance data is basically consistent with the compound prepared in Preparation Example 4. Molar yield: 92%, HPLC purity: 99%.
将原料(Z)-2-(2-(3,4-二甲氧基-5-硝基苯基)肼)丙酸乙酯(化合物式I-1-1)替换为(Z)-2-(2-(3,4-二乙氧基-5-硝基苯基)肼基)丙酸乙酯(化合物I-1-2),根据制备例4-6中所述的方法制备得到 (Z)-2-(2-(3-氨基-4,5-二乙氧基苯基)肼基)丙酸乙酯(化合物I-2-2),摩尔收率在90%以上,纯度在98%以上。The raw material (Z)-2-(2-(3,4-dimethoxy-5-nitrophenyl)hydrazine)propionic acid ethyl ester (compound formula I-1-1) is replaced with (Z)-2-(2-(3,4-diethoxy-5-nitrophenyl)hydrazine)propionic acid ethyl ester (compound I-1-2), and (Z)-2-(2-(3-amino-4,5-diethoxyphenyl)hydrazine)propionic acid ethyl ester (compound I-2-2) is prepared according to the method described in Preparation Example 4-6, with a molar yield of more than 90% and a purity of more than 98%.
实施例2化合物式II的制备Example 2 Preparation of Compound Formula II
制备例7:(Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二羧酸二甲酯(化合物II-1-2)的制备Preparation Example 7: Preparation of (Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid dimethyl ester (Compound II-1-2)
向反应瓶中投入562g化合物I-2-1(制备例4)和3000g二氯甲烷,搅拌均匀后,再加入980g(E)-4-氧代戊-2-烯二酸二甲酯和544g氯化锌,室温搅拌24h。反应完毕,先常压后减压蒸干溶剂。向剩余物中加入2000g 70%乙醇,加热至70℃搅拌30min,搅拌完毕,降温至15℃,析出浅黄色固体。抽滤,烘干,得到703g化合物II-1-2。摩尔收率:81.2%,HPLC纯度99.1%。Add 562g of compound I-2-1 (Preparation Example 4) and 3000g of dichloromethane to the reaction bottle, stir evenly, then add 980g of (E)-4-oxopentan-2-enedioic acid dimethyl ester and 544g of zinc chloride, and stir at room temperature for 24h. After the reaction is completed, evaporate the solvent at normal pressure and then at reduced pressure. Add 2000g of 70% ethanol to the residue, heat to 70℃ and stir for 30min, after stirring, cool to 15℃, and precipitate a light yellow solid. Filter and dry to obtain 703g of compound II-1-2. Molar yield: 81.2%, HPLC purity 99.1%.
制备例8:(Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二羧酸二乙酯(化合物II-1-3)的制备Preparation Example 8: Preparation of (Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid diethyl ester (Compound II-1-3)
向反应瓶中投入562g化合物I-2-1(制备例4)和3000g二氯甲烷,搅拌均匀后,再加入980g(E)-4-氧代戊-2-烯二酸二乙酯和544g氯化锌,于20-25℃搅拌反应24h。反应完毕,先常压后减压蒸干溶剂。向剩余物中加入2000g 70%乙醇,加热至70℃搅拌30min,搅拌完毕,降温至15℃,析出浅黄色固体。抽滤,烘干,得到733g化合物II-1-3。摩尔收率:79.5%,HPLC纯度99.1%Add 562g of compound I-2-1 (Preparation Example 4) and 3000g of dichloromethane into the reaction bottle, stir evenly, then add 980g of (E)-4-oxopentan-2-enedioic acid diethyl ester and 544g of zinc chloride, and stir at 20-25°C for 24h. After the reaction is completed, evaporate the solvent at normal pressure and then at reduced pressure. Add 2000g of 70% ethanol to the residue, heat to 70°C and stir for 30min. After stirring, cool to 15°C to precipitate a light yellow solid. Filter and dry to obtain 733g of compound II-1-3. Molar yield: 79.5%, HPLC purity 99.1%
制备例9:(Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二羧酸二丙酯(化合物II-1-4)的制备Preparation Example 9: Preparation of (Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid dipropyl ester (Compound II-1-4)
向反应瓶中投入562g化合物I-2-1(制备例4)和3000g乙腈,搅拌均匀后,再加入980g(E)-4-氧代戊-2-烯二酸二丙酯和544g氯化锌,室温下搅拌反应24h。反应完毕,先常压后减压蒸干溶剂。向剩余物中加入2000g 50%乙醇,加热至70℃搅拌30min,搅拌完毕,降温至15℃,析出浅黄色固体。抽滤,烘干,得到743.3g化合物式II-1-4。摩尔收率:76%,HPLC纯度99.1%Add 562g of compound I-2-1 (Preparation Example 4) and 3000g of acetonitrile to the reaction bottle, stir evenly, then add 980g of (E)-4-oxopentan-2-enedioic acid dipropyl ester and 544g of zinc chloride, and stir the reaction at room temperature for 24h. After the reaction is completed, evaporate the solvent at normal pressure and then at reduced pressure. Add 2000g of 50% ethanol to the residue, heat to 70°C and stir for 30min. After stirring, cool to 15°C to precipitate a light yellow solid. Filter and dry to obtain 743.3g of compound formula II-1-4. Molar yield: 76%, HPLC purity 99.1%
将制备例7-9中的原料(Z)-2-(2-(3-氨基-4,5-二甲氧基苯基)肼基)丙酸乙酯(化合物I-2-1)替换为(Z)-2-(2-(3-氨基-4,5-二乙氧基苯基)肼基)丙酸乙酯(化合物I-2-2),分别按照制备例7-9中所述的方法制备得到(Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二甲酸二甲酯(化合物II-2-2)、(Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二甲酸二乙酯(化合物II-2-3)和(Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二甲酸二丙酯(化合物II-2-4),其摩尔收率均在75%以上,HPLC纯度在99%以上。The raw material (Z)-2-(2-(3-amino-4,5-dimethoxyphenyl)hydrazine)propionic acid ethyl ester (Compound I-2-1) in Preparation Example 7-9 was replaced with (Z)-2-(2-(3-amino-4,5-diethoxyphenyl)hydrazine)propionic acid ethyl ester (Compound I-2-2), and (Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazine)quinoline-2,4-dimethoxybenzene was prepared according to the method described in Preparation Example 7-9. The molar yields of the following compounds were all above 75% and the HPLC purity was above 99%.
实施例3化合物式III的制备Example 3 Preparation of Compound III
制备例10:4,5-二甲氧基-7,9-双(甲氧基羰基)-1H-吡咯并[2,3-f]喹啉-2-甲酸乙酯(化合物III-1-2)的制备Preparation Example 10: Preparation of ethyl 4,5-dimethoxy-7,9-bis(methoxycarbonyl)-1H-pyrrolo[2,3-f]quinoline-2-carboxylate (Compound III-1-2)
向反应瓶中投入2200g硫酸和433g化合物II-1-2(制备例7),搅拌均匀,将反应体系升温至40℃搅拌反应16h。反应完毕,将反应液反加至8800g冰水混合液中,析出固体料,抽滤,固体料水洗至中性,抽滤,固体料烘干得382.7g化合物III-1-2。摩尔收率:92%,HPLC纯度99%。2200g sulfuric acid and 433g compound II-1-2 (Preparation Example 7) were added to the reaction flask, stirred evenly, and the reaction system was heated to 40°C and stirred for 16h. After the reaction was completed, the reaction solution was added back to 8800g of ice-water mixture to precipitate solid material, which was filtered, washed with water until neutral, filtered, and dried to obtain 382.7g compound III-1-2. Molar yield: 92%, HPLC purity 99%.
制备例11:4,5-二甲氧基-7,9-双(乙氧基羰基)-1H-吡咯并[2,3-f]喹啉-2-甲酸乙酯(化合物III-1-3)的制备Preparation Example 11: Preparation of ethyl 4,5-dimethoxy-7,9-bis(ethoxycarbonyl)-1H-pyrrolo[2,3-f]quinoline-2-carboxylate (Compound III-1-3)
向反应瓶中投入2200g硫酸和461g化合物II-1-3(制备例8),搅拌均匀,将反应体系升温至45-55℃搅拌反应16h。反应完毕,将反应液反加至8800g冰水混合液中,析出固体料,抽滤,固体料水洗至中性,抽滤,固体料烘干得390.7g化合物III-1-3。摩尔收率:88%,HPLC纯度99%。2200g sulfuric acid and 461g compound II-1-3 (Preparation Example 8) were added to the reaction flask, stirred evenly, and the reaction system was heated to 45-55°C and stirred for 16h. After the reaction was completed, the reaction solution was added back to 8800g of ice-water mixture to precipitate solid material, filtered, washed with water until neutral, filtered, and dried to obtain 390.7g compound III-1-3. Molar yield: 88%, HPLC purity 99%.
制备例12:4,5-二甲氧基-7,9-双[(丙基氧基)羰基]-1H-吡咯并[2,3-f]喹啉-2-甲酸乙酯(化合物III-1-4)的制备Preparation Example 12: Preparation of ethyl 4,5-dimethoxy-7,9-bis[(propyloxy)carbonyl]-1H-pyrrolo[2,3-f]quinoline-2-carboxylate (Compound III-1-4)
向反应瓶中投入2200g硫酸和489g化合物II-1-4(制备例9),搅拌均匀,将反应体系升温至30-40℃搅拌反应16h。反应完毕,将反应液反加至8800g冰水混合液中,析出固体料,抽滤,固体料水洗至中性,抽滤,固体料烘干得424.8g化合物式III-1-4。摩尔收率:90%,HPLC纯度98.6%。2200g sulfuric acid and 489g compound II-1-4 (Preparation Example 9) were added to the reaction bottle, stirred evenly, and the reaction system was heated to 30-40°C and stirred for 16h. After the reaction was completed, the reaction solution was added back to 8800g of ice-water mixture to precipitate solid material, filtered, washed with water until neutral, filtered, and dried to obtain 424.8g compound III-1-4. Molar yield: 90%, HPLC purity 98.6%.
将制备例10-12中的原料(Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二甲酸二甲酯(化合物II-1-2)、(Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二羧酸二乙酯(化合物II-1-3)和(Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二羧酸二丙酯(化合物II-1-4)分别替换为(Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二甲酸二甲酯(化合物II-2-2)、(Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二甲酸二乙酯(化合物II-2-3)和(Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二甲酸二丙酯(化合物II-2-4)分别按照制备例7-9中所述的方法制备得到4,5-二乙氧基-7,9-双(甲氧基羰基)-1H-吡咯并[2,3-f]喹啉-2-甲酸乙酯(化合物III-2-2)、4,5-二乙氧基-7,9-双(乙氧基羰基)-1H-吡咯并[2,3-f]喹啉-2-甲酸乙酯(化合物III-2-3)和4,5-二乙氧基-7,9-双[(丙基氧基)羰基]-1H-吡咯并[2,3-f]喹啉-2-甲酸乙酯(化合物III-2-4),其摩尔收率均在85%以上,HPLC纯度均在98%以上。The raw materials (Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid dimethyl ester (Compound II-1-2), (Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid diethyl ester (Compound II-1-3) and (Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid diethyl ester (Compound II-1-3) were prepared as follows: The dimethyl (Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylate (compound II-1-4) was replaced by dimethyl (Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)quinoline-2,4-dicarboxylate (compound II-2-2), (Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)quinoline-2,4-dicarboxylate (compound II-3-2), respectively. 4,5-diethoxy-7,9-bis(methoxycarbonyl)-1H-pyrrolo[2,3-f]quinoline-2-carboxylic acid ethyl ester (compound II-2-3) and (Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxoprop-2-ylidene)hydrazino)quinoline-2,4-dicarboxylic acid dipropyl ester (compound II-2-4) were prepared according to the method described in Preparation Example 7-9 to obtain 4,5-diethoxy-7,9-bis(methoxycarbonyl)-1H-pyrrolo[2,3-f]quinoline-2-carboxylic acid ethyl ester ( Compound III-2-2), 4,5-diethoxy-7,9-bis(ethoxycarbonyl)-1H-pyrrolo[2,3-f]quinoline-2-carboxylic acid ethyl ester (compound III-2-3) and 4,5-diethoxy-7,9-bis[(propyloxy)carbonyl]-1H-pyrrolo[2,3-f]quinoline-2-carboxylic acid ethyl ester (compound III-2-4), their molar yields are all above 85%, and their HPLC purities are all above 98%.
实施例4化合物式IV的制备Example 4 Preparation of Compound IV
制备例13:4,5-二甲氧基-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸(化合物IV-1)的制备Preparation Example 13: Preparation of 4,5-dimethoxy-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid (Compound IV-1)
向反应瓶中投入氢氧化钠160g和纯化水1680g,搅拌至固体料完全溶解,再投入433g化合物III-1-2(制备例10),投毕,升温至90℃搅拌反应8h。反应完毕,冷却至30℃,酸调至pH至2-3,抽滤,固体料水洗一次,抽滤,固体料90℃烘干得化合物IV-1,产量335g。摩尔收率93%,HPLC纯度98.5%。160 g of sodium hydroxide and 1680 g of purified water were added to the reaction flask, stirred until the solid material was completely dissolved, and then 433 g of compound III-1-2 (Preparation Example 10) was added. After the addition, the temperature was raised to 90 ° C and stirred for 8 h. After the reaction was completed, the mixture was cooled to 30 ° C, the acid was adjusted to pH 2-3, and the mixture was filtered. The solid material was washed with water once, filtered, and the solid material was dried at 90 ° C to obtain compound IV-1, with a yield of 335 g. The molar yield was 93%, and the HPLC purity was 98.5%.
制备例14:4,5-二甲氧基-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸(化合物IV-1)的制备Preparation Example 14: Preparation of 4,5-dimethoxy-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid (Compound IV-1)
向反应瓶中投入氢氧化钠160g和纯化水1680g,搅拌至固体料完全溶解,再投入461g化合物III-1-3(制备例11),投毕,升温至80-90℃搅拌反应8h。反应完毕,冷却至30℃,酸调至pH至2-3,抽滤,固体料水洗一次,抽滤,固体料90℃烘干得化合物IV-1,产量320g。摩尔收率88.9%,HPLC纯度98.7%。160 g of sodium hydroxide and 1680 g of purified water were added to the reaction flask, stirred until the solid material was completely dissolved, and then 461 g of compound III-1-3 (Preparation Example 11) was added. After the addition, the temperature was raised to 80-90 ° C and stirred for 8 hours. After the reaction was completed, it was cooled to 30 ° C, the acid was adjusted to pH 2-3, and the solid material was filtered. The solid material was washed with water once, filtered, and the solid material was dried at 90 ° C to obtain compound IV-1, with a yield of 320 g. The molar yield was 88.9%, and the HPLC purity was 98.7%.
制备例15:4,5-二甲氧基-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸(化合物IV-1)的制备Preparation Example 15: Preparation of 4,5-dimethoxy-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid (Compound IV-1)
向反应瓶中投入氢氧化钾224g和纯化水1680g,搅拌至固体料完全溶解,再投入化合物式III-1-4 489g(制备例12),投毕,升温至80-90℃搅拌反应8h。反应完毕,冷却至30℃,酸调至pH至2-3,抽滤,固体料水洗一次,抽滤,固体料90℃烘干得化合物IV-1,产量327.6g。摩尔收率91%,HPLC纯度99.05%。Add 224g of potassium hydroxide and 1680g of purified water to the reaction flask, stir until the solid material is completely dissolved, then add 489g of compound III-1-4 (Preparation Example 12), after adding, heat to 80-90℃ and stir to react for 8h. After the reaction is completed, cool to 30℃, adjust the pH to 2-3 with acid, filter, wash the solid material with water once, filter, dry the solid material at 90℃ to obtain compound IV-1, with a yield of 327.6g. Molar yield 91%, HPLC purity 99.05%.
将制备例13-15中的原料4,5-二甲氧基-7,9-双(甲氧基羰基)-1H-吡咯并[2,3-f]喹啉-2-甲酸乙酯(化合物式III-1-2)、4,5-二甲氧基-7,9-双(乙氧基羰基)-1H-吡咯并[2,3-f]喹啉-2-甲酸乙酯(化合物式III-1-3)和4,5-二甲氧基-7,9-双[(丙基氧基)羰基]-1H-吡咯并[2,3-f]喹啉-2-甲酸乙酯(化合物式III-1-4)分别替换为4,5-二乙氧基-7,9-双(甲氧基羰基)-1H-吡咯并[2,3-f]喹啉-2-甲酸乙酯(化合物III-2-2)、4,5-二乙氧基-7,9-双(乙氧基羰基)-1H-吡咯并[2,3-f]喹啉-2-甲酸乙酯(化合物III-2-3)和4,5-二乙氧基-7,9-双[(丙基氧基)羰基]-1H-吡咯并[2,3-f]喹啉-2-甲酸乙酯(化合物III-2-4),按照制备例13-15中的方法分别制备得到4,5-二乙氧基-1H-吡咯[2,3-f]喹啉-2,7,9-三羧酸(化合物IV-2),其摩尔收率88%以上,HPLC纯度98%以上。The raw materials 4,5-dimethoxy-7,9-bis(methoxycarbonyl)-1H-pyrrolo[2,3-f]quinoline-2-carboxylic acid ethyl ester (compound formula III-1-2), 4,5-dimethoxy-7,9-bis(ethoxycarbonyl)-1H-pyrrolo[2,3-f]quinoline-2-carboxylic acid ethyl ester (compound formula III-1-3) and 4,5-dimethoxy-7,9-bis[(propyloxy)carbonyl]-1H-pyrrolo[2,3-f]quinoline-2-carboxylic acid ethyl ester (compound formula III-1-4) in Preparation Example 13-15 were replaced by 4,5-diethoxy-7,9-bis(methoxycarbonyl)-1H-pyrrolo[2,3- f] quinoline-2-carboxylic acid ethyl ester (Compound III-2-2), 4,5-diethoxy-7,9-bis(ethoxycarbonyl)-1H-pyrrolo[2,3-f]quinoline-2-carboxylic acid ethyl ester (Compound III-2-3) and 4,5-diethoxy-7,9-bis[(propyloxy)carbonyl]-1H-pyrrolo[2,3-f]quinoline-2-carboxylic acid ethyl ester (Compound III-2-4) were prepared according to the methods in Preparation Examples 13-15 to obtain 4,5-diethoxy-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid (Compound IV-2) with a molar yield of more than 88% and an HPLC purity of more than 98%.
实施例5 4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸(PQQ)的制备Example 5 Preparation of 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid (PQQ)
制备例16:Preparation Example 16:
向反应瓶中投入360g化合物IV-1(制备例13)和1800g醋酸投入反应瓶中。将物料搅拌均匀后,于20-30℃向反应瓶中缓慢滴加40%HI 1080g溶液,滴加完毕,升温至60-70℃保温搅拌反应12h。反应完毕,将物料冷却至20℃,缓慢反加至3000g冰水中,析出固体料,抽滤,纯 化水洗涤固体料至pH至4-5,抽滤,固体料用甲醇重结晶,固体料得中间体化合物VI湿品587.6g。将中间体化合物VI湿品587.6g和1800g 30%过氧化氢溶液投入反应瓶中,搅拌,使反应瓶中物料搅拌均匀。升温至35℃,于30-35℃搅拌反应24h。反应完毕,降温至20℃,抽滤,固体料于90℃烘干得PQQ 297g。摩尔收率90%,HPLC纯度99.5%。360g of compound IV-1 (Preparation Example 13) and 1800g of acetic acid were added to the reaction flask. After the materials were stirred evenly, 1080g of 40% HI solution was slowly added to the reaction flask at 20-30°C. After the addition was completed, the temperature was raised to 60-70°C and stirred for 12h. After the reaction was completed, the materials were cooled to 20°C and slowly added to 3000g of ice water to precipitate solid materials, filtered, and washed with purified water until the pH reached 4-5. The solid materials were filtered and recrystallized with methanol to obtain 587.6g of intermediate compound VI wet product. 587.6g of intermediate compound VI wet product and 1800g of 30% hydrogen peroxide solution were added to the reaction flask and stirred to make the materials in the reaction flask evenly stirred. The temperature was raised to 35°C and stirred at 30-35°C for 24h. After the reaction was completed, the temperature was lowered to 20°C, filtered, and the solid materials were dried at 90°C to obtain 297g of PQQ. The molar yield was 90%, and the HPLC purity was 99.5%.
制备例17:Preparation Example 17:
向反应瓶中投入360g化合物IV-1(制备例13)和1800g醋酸投入反应瓶中。将物料搅拌均匀后,于30-40℃向反应瓶中缓慢滴加40%HI 1080g溶液,滴加完毕,升温至70-80℃保温搅拌反应12h。反应完毕,将物料冷却至20℃,缓慢反加至3000g冰水中,析出固体料,抽滤,纯化水洗涤固体料至pH至4-5,抽滤,固体料用甲醇重结晶,固体料得中间体化合物VI湿品544.4g。将中间体化合物VI湿品544.4g和1800g 30%过氧化氢溶液投入反应瓶中,搅拌,使反应瓶中物料搅拌均匀。升温至35℃,于30-35℃搅拌反应24h。反应完毕,降温至20℃,抽滤,固体料于90℃烘干得PQQ 292.7g。摩尔收率88.7%,HPLC纯度99.5%。360g of compound IV-1 (Preparation Example 13) and 1800g of acetic acid were added to the reaction flask. After the materials were stirred evenly, 1080g of 40% HI solution was slowly added to the reaction flask at 30-40°C. After the addition was completed, the temperature was raised to 70-80°C and stirred for 12h. After the reaction was completed, the materials were cooled to 20°C and slowly added to 3000g of ice water to precipitate solid materials, filtered, and the solid materials were washed with purified water until the pH reached 4-5, filtered, and the solid materials were recrystallized with methanol. The solid materials obtained 544.4g of intermediate compound VI wet product. 544.4g of intermediate compound VI wet product and 1800g of 30% hydrogen peroxide solution were added to the reaction flask and stirred to stir the materials in the reaction flask evenly. The temperature was raised to 35°C and stirred at 30-35°C for 24h. After the reaction was completed, the temperature was lowered to 20°C, filtered, and the solid materials were dried at 90°C to obtain 292.7g of PQQ. The molar yield was 88.7%, and the HPLC purity was 99.5%.
制备例18:Preparation Example 18:
向反应瓶中投入360g化合物IV-1(制备例13)和1800g醋酸投入反应瓶中。将物料搅拌均匀后,于20-30℃向反应瓶中缓慢滴加30%HI 1080g溶液,滴加完毕,升温至60-70℃保温搅拌反应12h。反应完毕,将物料冷却至20℃,缓慢反加至3000g冰水中,析出固体料,抽滤,纯化水洗涤固体料至pH至4-5,抽滤,固体料用甲醇重结晶,固体料得中间体化合物VI湿品568g。将中间体化合物VI湿品568g和1800g 30%过氧化氢溶液投入反应瓶中,搅拌,使反应瓶中物料搅拌均匀。升温至35℃,于30-35℃搅拌反应24h。反应完毕,降温至20℃,抽滤,固体料于90℃烘干得PQQ 290g。摩尔收率87.9%,HPLC纯度99.5%。360g of compound IV-1 (Preparation Example 13) and 1800g of acetic acid were added to the reaction flask. After the materials were stirred evenly, 1080g of 30% HI solution was slowly added to the reaction flask at 20-30°C. After the addition was completed, the temperature was raised to 60-70°C and stirred for 12h. After the reaction was completed, the materials were cooled to 20°C and slowly added to 3000g of ice water to precipitate solid materials, filtered, and the solid materials were washed with purified water until the pH reached 4-5, filtered, and the solid materials were recrystallized with methanol to obtain 568g of intermediate compound VI wet product. 568g of intermediate compound VI wet product and 1800g of 30% hydrogen peroxide solution were added to the reaction flask and stirred to stir the materials in the reaction flask evenly. The temperature was raised to 35°C and stirred at 30-35°C for 24h. After the reaction was completed, the temperature was lowered to 20°C, filtered, and the solid materials were dried at 90°C to obtain 290g of PQQ. The molar yield was 87.9%, and the HPLC purity was 99.5%.
将原料2-(乙氧羰基)-4,5-二甲氧基-1H-吡咯并[2,3-f]喹啉-7,9-二羧酸(化合物IV-1)替换为4,5-二乙氧基-2-(乙氧基羰基)-1H-吡咯并[2,3-f]喹啉-7,9-二羧酸(化合物IV-2),按照制备例16-18中所述的方法制备PQQ,其摩尔收率在86%以上,HPLC纯度在99%以上。The raw material 2-(ethoxycarbonyl)-4,5-dimethoxy-1H-pyrrolo[2,3-f]quinoline-7,9-dicarboxylic acid (compound IV-1) was replaced with 4,5-diethoxy-2-(ethoxycarbonyl)-1H-pyrrolo[2,3-f]quinoline-7,9-dicarboxylic acid (compound IV-2), and PQQ was prepared according to the method described in Preparation Examples 16-18, with a molar yield of more than 86% and an HPLC purity of more than 99%.
对比例Comparative Example
本对比例以N-(5-氨基-3-溴-2-甲氧基苯基)乙酰胺为中间体制备PQQ,在反应过程中尝试先合成喹啉环,再合成吲哚环,按照以下反应路线进行:In this comparative example, N-(5-amino-3-bromo-2-methoxyphenyl)acetamide was used as an intermediate to prepare PQQ. During the reaction, the quinoline ring was first synthesized, and then the indole ring was synthesized. The reaction was carried out according to the following reaction route:
Figure PCTCN2022142378-appb-000014
Figure PCTCN2022142378-appb-000014
其中,在第3步反应中,化合物C在闭合形成喹啉环的同时也会闭合形成吲哚环,因而该步骤存在副反应,严重影响收率和产率,该步的摩尔收率仅为52%,HPLC纯度仅为约98%,而本申请上述实施例中在合成喹啉环时摩尔收率均能够保持在75%以上,HPLC纯度在99%以上;同时,起始物苯环上的溴原子还需要在第6步通过乌尔曼反应把-Br变成-OCH 3,反应路线变长,导致最终的收率和纯度进一步下降,反应路线的总收率不足20%。目前现有的制备PQQ的中间体往往都存在这个问题,所以现有技术中的中间体会选择先闭合吲哚环,再闭合喹啉环。 Among them, in the third step reaction, compound C will close to form an indole ring while closing to form a quinoline ring, so there is a side reaction in this step, which seriously affects the yield and productivity. The molar yield of this step is only 52%, and the HPLC purity is only about 98%. In the above embodiments of the present application, the molar yield can be maintained at more than 75% when synthesizing the quinoline ring, and the HPLC purity is more than 99%; at the same time, the bromine atom on the benzene ring of the starting material needs to be converted from -Br to -OCH3 through the Ullmann reaction in the sixth step, and the reaction route becomes longer, resulting in a further decrease in the final yield and purity, and the total yield of the reaction route is less than 20%. At present, the existing intermediates for preparing PQQ often have this problem, so the intermediates in the prior art will choose to close the indole ring first and then close the quinoline ring.
具体地,具体操作过程如下:Specifically, the specific operation process is as follows:
(1)于洗净干燥的反应瓶中投入30%盐酸1200g和500g无水乙醇和化合物A147.5g投毕,冷却至反应液至-5℃搅拌反应1h。当内温达到-5℃时,开始快速搅拌下滴加197g 40%醋酸钠,控制滴加速度,使内温不高于5℃。滴毕,0~5℃搅拌120~180min,检测化合物A消失为准。(1) Add 1200 g of 30% hydrochloric acid, 500 g of anhydrous ethanol and 147.5 g of compound A to a clean and dry reaction bottle, cool the reaction solution to -5°C and stir for 1 hour. When the internal temperature reaches -5°C, begin to add 197 g of 40% sodium acetate dropwise with rapid stirring, and control the dropping speed so that the internal temperature does not exceed 5°C. After the addition is completed, stir at 0-5°C for 120-180 min, and detect the disappearance of compound A.
用冷阱冷却至-15℃,然后加入2-甲基乙酰乙酸乙酯144g。加毕,冷却反应液至-10~-15℃。开始流加30%乙酸钠462g,控制流加速度,使内温不高于-5℃。滴加完毕,快速搅拌下缓慢升温于20~25℃搅拌反应12h。反应完毕,冷却反应液至0℃以下,抽滤,固体料水洗二遍,离心,固体料烘干得150g化合物B。摩尔收率80%,HPLC纯度98.6%。Cool to -15°C with a cold trap, then add 144g of ethyl 2-methylacetoacetate. After the addition, cool the reaction solution to -10 to -15°C. Start to add 462g of 30% sodium acetate, control the flow acceleration so that the internal temperature is not higher than -5°C. After the addition is complete, slowly heat up to 20 to 25°C with rapid stirring and stir for 12h. After the reaction is complete, cool the reaction solution to below 0°C, filter, wash the solid material with water twice, centrifuge, and dry the solid material to obtain 150g of compound B. The molar yield is 80%, and the HPLC purity is 98.6%.
(2)于洗净干燥的反应瓶上安装回流冷凝器。安装完毕,将乙醇1300g和甲磺酸200g 及化合物B 372g投入反应瓶。投毕,升温至80~85℃回流反应6h(液相检测底物反应完全)。反应完毕,冷却至20℃,开始流加10%碳酸钠1000g,加毕,升温回流1h。检测反应液pH=7-8(以pH为准),冷却,析出结晶,抽滤,固体料暂存,乙醇滤液回收乙醇,剩余物冷却析晶,抽滤,固体料合并,水洗残盐,烘干,得化合物C 247.5g。摩尔收率75%,HPLC纯度99.3%。(2) Install a reflux condenser on the clean and dried reaction bottle. After installation, add 1300 g of ethanol, 200 g of methanesulfonic acid and 372 g of compound B into the reaction bottle. After addition, heat to 80-85 °C and reflux for 6 h (liquid phase detection shows that the substrate reaction is complete). After the reaction is completed, cool to 20 °C and start adding 1000 g of 10% sodium carbonate. After addition, heat and reflux for 1 h. Detect the pH of the reaction solution to be 7-8 (based on pH), cool, crystallize, filter, store the solid material temporarily, recover ethanol from the ethanol filtrate, cool the residue and crystallize, filter, combine the solid materials, wash the residual salt with water, and dry to obtain 247.5 g of compound C. The molar yield is 75%, and the HPLC purity is 99.3%.
(3)向反应瓶中投入165g化合物C和1500g二氯甲烷,搅拌均匀后,再加入490g(E)-4-氧代戊-2-烯二酸二丙酯和25g氯化锌,室温搅拌24h。反应完毕,先常压后减压蒸干溶剂。向剩余物中加入1000g 70%乙醇,加热至70℃搅拌30min,搅拌完毕,降温至15℃以下,析出浅黄色固体。抽滤,烘干,得到145g化合物D。摩尔收率52%,HPLC纯度98%。(3) Add 165g of compound C and 1500g of dichloromethane to the reaction flask, stir evenly, then add 490g of (E)-4-oxopentan-2-enedioic acid dipropyl ester and 25g of zinc chloride, and stir at room temperature for 24h. After the reaction is completed, evaporate the solvent at normal pressure and then at reduced pressure. Add 1000g of 70% ethanol to the residue, heat to 70°C and stir for 30min. After stirring, cool to below 15°C to precipitate a light yellow solid. Filter and dry to obtain 145g of compound D. The molar yield is 52%, and the HPLC purity is 98%.
(4)于洗净干燥的反应瓶中投入甲磺酸2000g和化合物D 538g。投毕,升温至70℃搅拌反应24h(液相检测底物反应完全)。反应完毕,反应液加到15000冰水中控制温度不高于40℃搅拌1h,析出结晶,搅拌下用10%碳酸钠调pH至6-7,抽滤,固体料1000g水洗残盐后,冷却反应液至20℃结晶1h。抽滤,固体料烘干(水分小于0.5%),得化合物E 468.9g。摩尔收率90%,HPLC纯度98.8%。(4) Add 2000 g of methanesulfonic acid and 538 g of compound D to a clean and dry reaction bottle. After addition, heat to 70 °C and stir for 24 h (liquid phase detection shows that the substrate reaction is complete). After the reaction is completed, add the reaction solution to 15,000 °C of ice water and control the temperature to no higher than 40 °C and stir for 1 h to precipitate crystals. Adjust the pH to 6-7 with 10% sodium carbonate while stirring, filter with suction, wash the residual salt with 1000 g of solid material, and cool the reaction solution to 20 °C for 1 h to crystallize. Filter with suction, dry the solid material (water content less than 0.5%), and obtain 468.9 g of compound E. The molar yield is 90%, and the HPLC purity is 98.8%.
(5)于洗净干燥的反应瓶上安装回流冷凝器。安装完毕,将30%甲醇/甲醇钠1800g、吡啶1500g、CuI48g和260.5g化合物E投入反应瓶。投毕,升温回流反8h。反应完毕,减压蒸除甲醇和吡啶至最高内温110℃。剩余物中加入2000g水,再升温至80-85℃,当温度到达90-95℃时保温反应2h。反应完毕,冷却反应液至30℃,抽滤,滤液用稀硫酸调pH值2-3,析出大量晶体,抽滤,固料加入水,1000-2000g水煮残酸和硫酸铜一遍,冷却抽滤,烘干,得化合物F153g,摩尔收率85%,HPLC纯度98.5%。(5) Install a reflux condenser on the clean and dried reaction bottle. After installation, add 1800g of 30% methanol/sodium methoxide, 1500g of pyridine, 48g of CuI and 260.5g of compound E into the reaction bottle. After addition, heat and reflux for 8h. After the reaction is completed, remove methanol and pyridine under reduced pressure until the maximum internal temperature is 110°C. Add 2000g of water to the residue, heat it to 80-85°C, and keep it warm for 2h when the temperature reaches 90-95°C. After the reaction is completed, cool the reaction liquid to 30°C and filter it. Adjust the pH value of the filtrate to 2-3 with dilute sulfuric acid to precipitate a large number of crystals. Filter it, add water to the solid material, boil the residual acid and copper sulfate with 1000-2000g of water, cool and filter it, and dry it to obtain 153g of compound F with a molar yield of 85% and a HPLC purity of 98.5%.
(6)于洗净干燥的反应瓶上安装回流冷凝器。安装完毕,将30%甲醇/甲醇钠3600g、吡啶3000g、CuI96g和化合物F 521g投入反应瓶。投毕,升温回流反8h。反应完毕,减压蒸除甲醇和吡啶至最高内温90℃。剩余物中加入4000g水,再升温至80-85℃,当温度到达90-95℃时保温反应2h。反应完毕,冷却反应液至30℃,滤液用稀硫酸调pH值2-3,析出大量晶体,冷却抽滤,烘干,得化合物G 325.8g,摩尔收率90.5%,HPLC纯度:99.2%。(6) Install a reflux condenser on the clean and dried reaction bottle. After installation, add 3600g of 30% methanol/sodium methoxide, 3000g of pyridine, 96g of CuI and 521g of compound F into the reaction bottle. After addition, heat and reflux for 8h. After the reaction is completed, remove methanol and pyridine under reduced pressure to a maximum internal temperature of 90°C. Add 4000g of water to the residue, heat it to 80-85°C, and keep it warm for 2h when the temperature reaches 90-95°C. After the reaction is completed, cool the reaction solution to 30°C, adjust the pH value of the filtrate to 2-3 with dilute sulfuric acid, precipitate a large amount of crystals, cool, filter, and dry to obtain 325.8g of compound G, with a molar yield of 90.5% and HPLC purity of 99.2%.
(7)向反应瓶中投入化合物G 360g和1800g醋酸投入反应瓶中。将物料搅拌均匀后,于20-30℃向反应瓶中缓慢滴加30%HI 1080g溶液,滴加完毕,升温至60-70℃保温搅拌反应12h。反应完毕,将物料冷却至20℃以下,缓慢反加至3000g冰水中,析出固体料,抽滤,纯化水洗涤固体料至PH至4-5,抽滤,固体料用甲醇重结晶,固体料得化合物PQQ中间体湿品568g。将化合物G中间体湿品568g和1800g 30%过氧化氢溶液投入反应瓶中,搅拌, 使反应瓶中物料搅拌均匀。升温至35℃,于30-35℃搅拌反应24h。反应完毕,降温至20℃以下,离心,固体料于90℃烘干得化合物PQQ 290g。摩尔收率87.9%,HPLC纯度99.5%。(7) Add 360 g of compound G and 1800 g of acetic acid to the reaction flask. After the materials are stirred evenly, slowly add 1080 g of 30% HI solution to the reaction flask at 20-30°C. After the addition is complete, heat to 60-70°C and stir for 12 h. After the reaction is complete, cool the materials to below 20°C and slowly add them back to 3000 g of ice water to precipitate solid materials. Filter and wash the solid materials with purified water until the pH reaches 4-5. Filter and recrystallize the solid materials with methanol to obtain 568 g of wet intermediate of compound PQQ. Add 568 g of wet intermediate of compound G and 1800 g of 30% hydrogen peroxide solution to the reaction flask and stir to make the materials in the reaction flask evenly stirred. Heat to 35°C and stir at 30-35°C for 24 h. After the reaction is complete, cool to below 20°C, centrifuge, and dry the solid materials at 90°C to obtain 290 g of compound PQQ. The molar yield was 87.9%, and the HPLC purity was 99.5%.
以上所述仅为本申请的优选实施例而已,并不用于限制本申请,尽管参照前述实施例对本申请进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本申请的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本申请的保护范围之内。The above description is only a preferred embodiment of the present application and is not intended to limit the present application. Although the present application is described in detail with reference to the aforementioned embodiments, those skilled in the art can still modify the technical solutions described in the aforementioned embodiments or replace some of the technical features therein by equivalents. Any modification, equivalent replacement, improvement, etc. made within the spirit and principles of the present application shall be included in the protection scope of the present application.

Claims (10)

  1. 一种制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸的方法,所述方法包括:以式II化合物为起始原料通过Fischer吲哚合成法制备式III化合物,水解式III化合物制备式IV化合物,氧化式IV化合物制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸;A method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the method comprising: using a compound of formula II as a starting material to prepare a compound of formula III by a Fischer indole synthesis method, hydrolyzing the compound of formula III to prepare a compound of formula IV, and oxidizing the compound of formula IV to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid;
    Figure PCTCN2022142378-appb-100001
    Figure PCTCN2022142378-appb-100001
    其中,R 1为C 1-C 3直链或支链烷基;R 3选自氢和C 1-C 3直链或支链烷基。 Wherein, R1 is a C1 - C3 straight chain or branched alkyl group; R3 is selected from hydrogen and a C1 - C3 straight chain or branched alkyl group.
  2. 一种制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸的方法,所述方法包括:以式I-2化合物为起始原料与式V化合物在Lewis酸催化作用下制备式II化合物,式II化合物通过Fischer吲哚合成法制备式III化合物,之后水解式III化合物制备式IV化合物,氧化式IV化合物制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸;A method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the method comprising: using a compound of formula I-2 as a starting material and a compound of formula V to prepare a compound of formula II under the catalysis of Lewis acid, preparing a compound of formula III from the compound of formula II by Fischer indole synthesis, then hydrolyzing the compound of formula III to prepare a compound of formula IV, and oxidizing the compound of formula IV to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid;
    Figure PCTCN2022142378-appb-100002
    Figure PCTCN2022142378-appb-100002
    其中,R 1为C 1-C 3直链或支链烷基;R 3选自氢和C 1-C 3直链或支链烷基。 Wherein, R1 is a C1 - C3 straight chain or branched alkyl group; R3 is selected from hydrogen and a C1 - C3 straight chain or branched alkyl group.
  3. 一种制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸的方法,所述方法包括:以式I-1化合物为起始原料,还原式I-1制备式I-2,然后式I-2与式V化合物在Lewis酸催化作用下制备式II化合物,之后式II化合物通过Fischer吲哚合成法制备式III化合物,然后水解式III化合物制备式IV化合物,氧化式IV化合物制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸;A method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the method comprising: using a compound of formula I-1 as a starting material, reducing formula I-1 to prepare formula I-2, then preparing a compound of formula II with a compound of formula V under the catalysis of Lewis acid, then preparing a compound of formula III from the compound of formula II by Fischer indole synthesis, then hydrolyzing the compound of formula III to prepare a compound of formula IV, and oxidizing the compound of formula IV to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid;
    Figure PCTCN2022142378-appb-100003
    Figure PCTCN2022142378-appb-100003
    其中,R 1为C 1-C 3直链或支链烷基;R 3选自氢和C 1-C 3直链或支链烷基。 Wherein, R1 is a C1 - C3 straight chain or branched alkyl group; R3 is selected from hydrogen and a C1 - C3 straight chain or branched alkyl group.
  4. 一种制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸的方法,所述方法包括:以式X化合物为起始原料,式X化合物进行重氮化后与2-甲基乙酰乙酸乙酯缩合制备式I-1化合物,还原式I-1化合物制备式I-2化合物,然后式I-2化合物与式V化合物在Lewis酸催化作用下制备式II化合物,之后式II化合物通过Fischer吲哚合成法制备式III化合物,然后水解式III化合物制备式IV化合物,氧化式IV化合物制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸;A method for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the method comprising: using a compound of formula X as a starting material, diazotizing the compound of formula X and condensing it with ethyl 2-methylacetoacetate to prepare a compound of formula I-1, reducing the compound of formula I-1 to prepare a compound of formula I-2, then reacting the compound of formula I-2 with a compound of formula V under Lewis acid catalysis to prepare a compound of formula II, then using the compound of formula II to prepare a compound of formula III through a Fischer indole synthesis method, then hydrolyzing the compound of formula III to prepare a compound of formula IV, and oxidizing the compound of formula IV to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid;
    Figure PCTCN2022142378-appb-100004
    Figure PCTCN2022142378-appb-100004
    其中,R 1为C 1-C 3直链或支链烷基;R 3选自氢和C 1-C 3直链或支链烷基。 Wherein, R1 is a C1 - C3 straight chain or branched alkyl group; R3 is selected from hydrogen and a C1 - C3 straight chain or branched alkyl group.
  5. 根据权利要求1至4中任一项所述的方法,其特征在于,氧化4,5-二甲氧基-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸包括:将4,5-二甲氧基-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸与质子酸反应制备得到2-(乙氧羰基)-4,5-二羟基-1H-吡咯并[2,3-f]喹啉-7,9-二羧酸,然后氧化2-(乙氧羰基)-4,5-二羟基-1H-吡咯并[2,3-f]喹啉 -7,9-二羧酸以制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸。The method according to any one of claims 1 to 4, characterized in that the oxidation of 4,5-dimethoxy-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid comprises: reacting 4,5-dimethoxy-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid with a protonic acid to prepare 2-(ethoxycarbonyl)-4,5-dihydroxy-1H-pyrrolo[2,3-f]quinoline-7,9-dicarboxylic acid, and then oxidizing 2-(ethoxycarbonyl)-4,5-dihydroxy-1H-pyrrolo[2,3-f]quinoline-7,9-dicarboxylic acid to prepare 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid.
  6. 根据权利要求1至4中任一项所述的方法,其特征在于,R 1为甲基或乙基,R 3为甲基、乙基或丙基; The method according to any one of claims 1 to 4, characterized in that R 1 is methyl or ethyl, and R 3 is methyl, ethyl or propyl;
    优选地,式X化合物与亚硝酸钠溶液在酸性条件下重氮化,再与2-甲基乙酰乙酸乙酯在碱性条件下缩合形成式I-1化合物;优选地,式X化合物与2-甲基乙酰乙酸乙酯的摩尔比为1:1-5;优选地,该步骤反应阶段的温度控制在-10℃-0℃;Preferably, the compound of formula X is diazotized with sodium nitrite solution under acidic conditions, and then condensed with ethyl 2-methylacetoacetate under alkaline conditions to form the compound of formula I-1; preferably, the molar ratio of the compound of formula X to ethyl 2-methylacetoacetate is 1:1-5; preferably, the temperature of the reaction stage of this step is controlled at -10°C-0°C;
    优选地,式I-1化合物在还原剂作用下发生还原反应制得式I-2化合物,优选该步骤的反应温度为60-80℃;Preferably, the compound of formula I-1 undergoes a reduction reaction under the action of a reducing agent to obtain a compound of formula I-2, and the reaction temperature of this step is preferably 60-80°C;
    优选地,在制备式II化合物时,化合物式I-2与式V化合物的摩尔比为1:1-5;Preferably, when preparing the compound of formula II, the molar ratio of the compound of formula I-2 to the compound of formula V is 1:1-5;
    优选地,在制备式III化合物时,反应温度控制在30-55℃;Preferably, when preparing the compound of formula III, the reaction temperature is controlled at 30-55°C;
    优选地,水解式III化合物制备式IV化合物在碱性环境中发生,优选控制温度在80-90℃;Preferably, the hydrolysis of the compound of formula III to prepare the compound of formula IV occurs in an alkaline environment, preferably at a temperature of 80-90° C.;
    优选地,采用氧化剂氧化式IV化合物,所述氧化剂选自双氧水、浓硫酸、浓硝酸和臭氧中的一种或多种。Preferably, the compound of formula IV is oxidized with an oxidant, wherein the oxidant is selected from one or more of hydrogen peroxide, concentrated sulfuric acid, concentrated nitric acid and ozone.
  7. 一种用于制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸的化合物,其结构如式I或式II中所示:A compound for preparing 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, the structure of which is as shown in Formula I or Formula II:
    Figure PCTCN2022142378-appb-100005
    Figure PCTCN2022142378-appb-100005
    其中,R 1为C 1-C 3直链或支链烷基,R 2为硝基或氨基,R 3选自氢和C 1-C 3直链或支链烷基。 Wherein, R1 is a C1 - C3 straight chain or branched chain alkyl group, R2 is a nitro group or an amino group, and R3 is selected from hydrogen and a C1 - C3 straight chain or branched chain alkyl group.
  8. 根据权利要求7所述的化合物,其特征在于,所述化合物具有如下所示的结构:The compound according to claim 7, characterized in that the compound has the structure shown below:
    Figure PCTCN2022142378-appb-100006
    Figure PCTCN2022142378-appb-100006
    其中,R 1为甲基或乙基,R 3为氢、甲基、乙基或丙基; Wherein, R1 is methyl or ethyl, and R3 is hydrogen, methyl, ethyl or propyl;
    优选地,所述化合物选自以下结构:Preferably, the compound is selected from the following structures:
    (Z)-2-(2-(3,4-二甲氧基-5-硝基苯基)肼基)丙酸乙酯;(Z)-ethyl 2-(2-(3,4-dimethoxy-5-nitrophenyl)hydrazino)propanoate;
    (Z)-2-(2-(3,4-二乙氧基-5-硝基苯基)肼基)丙酸乙酯;(Z)-ethyl 2-(2-(3,4-diethoxy-5-nitrophenyl)hydrazinyl)propanoate;
    (Z)-2-(2-(3-氨基-4,5-二甲氧基苯基)肼基)丙酸乙酯;(Z)-ethyl 2-(2-(3-amino-4,5-dimethoxyphenyl)hydrazino)propanoate;
    (Z)-2-(2-(3-氨基-4,5-二乙氧基苯基)肼基)丙酸乙酯;(Z)-ethyl 2-(2-(3-amino-4,5-diethoxyphenyl)hydrazinyl)propanoate;
    (Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二羧酸;(Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid;
    (Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二甲酸二甲酯;(Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid dimethyl ester;
    (Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二羧酸二乙酯;(Z)-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylic acid diethyl ester;
    (Z)-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)-7,8-二甲氧基喹啉-2,4-二羧酸二丙酯;(Z)-dipropyl 5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)-7,8-dimethoxyquinoline-2,4-dicarboxylate;
    (Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二羧酸;(Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)quinoline-2,4-dicarboxylic acid;
    (Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二甲酸二甲酯;(Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)quinoline-2,4-dicarboxylic acid dimethyl ester;
    (Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二甲酸二乙酯;(Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)quinoline-2,4-dicarboxylic acid diethyl ester;
    (Z)-7,8-二乙氧基-5-(2-(1-乙氧基-1-氧代丙-2-亚基)肼基)喹啉-2,4-二甲酸二丙酯。(Z)-7,8-diethoxy-5-(2-(1-ethoxy-1-oxopropan-2-ylidene)hydrazino)quinoline-2,4-dicarboxylic acid dipropyl ester.
  9. 权利要求7或8中所述的化合物和/或式X化合物作为中间体在制备4,5-二氧代-4,5-二氢-1H-吡咯并[2,3-f]喹啉-2,7,9-三羧酸中的应用;Use of the compound described in claim 7 or 8 and/or the compound of formula X as an intermediate in the preparation of 4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid;
    Figure PCTCN2022142378-appb-100007
    Figure PCTCN2022142378-appb-100007
    其中,R 1为C 1-C 3直链或支链烷基,R 2为硝基或氨基;R 3选自氢和C 1-C 3直链或支链烷基。 Wherein, R1 is a C1 - C3 straight chain or branched alkyl group, R2 is a nitro group or an amino group; and R3 is selected from hydrogen and a C1 - C3 straight chain or branched alkyl group.
  10. 根据权利要求9所述的应用,其特征在于,R 1为甲基或乙基,R 2为硝基或氨基,R 3为氢、甲基、乙基或丙基。 The use according to claim 9, characterized in that R1 is methyl or ethyl, R2 is nitro or amino, and R3 is hydrogen, methyl, ethyl or propyl.
PCT/CN2022/142378 2022-11-11 2022-12-27 Intermediate and method for preparing pyrroloquinoline quinone WO2024098530A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202211415318.7 2022-11-11
CN202211415318.7A CN115894483A (en) 2022-11-11 2022-11-11 Intermediate and method for preparing pyrroloquinoline quinone

Publications (1)

Publication Number Publication Date
WO2024098530A1 true WO2024098530A1 (en) 2024-05-16

Family

ID=86494987

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/142378 WO2024098530A1 (en) 2022-11-11 2022-12-27 Intermediate and method for preparing pyrroloquinoline quinone

Country Status (2)

Country Link
CN (1) CN115894483A (en)
WO (1) WO2024098530A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070072894A1 (en) * 2005-03-24 2007-03-29 Kempf J V Synthesis of pyrroloquinoline quinone (PQQ)
US20140364613A1 (en) * 2013-06-06 2014-12-11 Anthem Biosciences Pvt.Ltd Compounds of 3-(5-sustituted oxy-2, 4-dinitrophenyl)-2-oxo-propionic acid ester, synthesis and applications thereof
CN104557921A (en) * 2014-12-24 2015-04-29 常熟理工学院 Synthetic method of pyrroloquinoline quinone
CN107089982A (en) * 2017-05-11 2017-08-25 山东康迈祺生物科技有限公司 4,5 two 1 hydrogen pyrroles of substitution (2,3 f) quinoline 2,7,9 tricarboxylic ester compounds and applications
CN110981873A (en) * 2019-12-31 2020-04-10 江西农业大学 Preparation method for synthesizing pyrroloquinoline quinone by five-step method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101193888A (en) * 2005-03-24 2008-06-04 Clf医疗技术加速程序有限公司 Synthesis of pyrroloquinoline quinone (PQQ)
CN111087395A (en) * 2019-12-31 2020-05-01 江西农业大学 Preparation method for synthesizing pyrroloquinoline quinone by four-step method

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070072894A1 (en) * 2005-03-24 2007-03-29 Kempf J V Synthesis of pyrroloquinoline quinone (PQQ)
US20140364613A1 (en) * 2013-06-06 2014-12-11 Anthem Biosciences Pvt.Ltd Compounds of 3-(5-sustituted oxy-2, 4-dinitrophenyl)-2-oxo-propionic acid ester, synthesis and applications thereof
CN105473544A (en) * 2013-06-06 2016-04-06 安瑟生物科技私人有限公司 Compounds of '3-(5-sustituted oxy-2,4-dinitro-phenyl)-2-oxo-propionic acid ester', process and applications thereof
CN104557921A (en) * 2014-12-24 2015-04-29 常熟理工学院 Synthetic method of pyrroloquinoline quinone
CN107089982A (en) * 2017-05-11 2017-08-25 山东康迈祺生物科技有限公司 4,5 two 1 hydrogen pyrroles of substitution (2,3 f) quinoline 2,7,9 tricarboxylic ester compounds and applications
CN110981873A (en) * 2019-12-31 2020-04-10 江西农业大学 Preparation method for synthesizing pyrroloquinoline quinone by five-step method

Also Published As

Publication number Publication date
CN115894483A (en) 2023-04-04

Similar Documents

Publication Publication Date Title
WO2024098530A1 (en) Intermediate and method for preparing pyrroloquinoline quinone
CN111320603A (en) Preparation method of lipoic acid process impurities
CN108191858B (en) A kind of intermediate preparing pyrroloquinoline quinone and preparation method
JPS582222B2 (en) Production method of aromatic polycarboxylic acid
CN110305070B (en) Method for synthesizing tetrazoleacetic acid by hydrazine hydrate method
WO2024098531A1 (en) Intermediate and use and method of intermediate in preparation of pyrroloquinoline quinone
CN109942397B (en) Preparation method of royal jelly acid
EP0968994B1 (en) Process for producing substituted trifluorobenzoic acids and esters thereof
JPH03135983A (en) Preparation of 1,1-dioxo-7-substituted cephem
CN109836322B (en) Preparation method of royal jelly acid
US5945556A (en) Process for preparing N-carboxymethylene-4-chloro-anthranilic acid and its dialkyl esters
CN112341351B (en) Preparation method of 2-amino-4-bromo-3-fluoro-5-iodobenzamide
US4526984A (en) Autoxidation of alkyl-substituted aromatic ethers
CN109422767B (en) Methoxycephalosporin intermediate, preparation method thereof and synthesis method of cefminox sodium
CN108409701B (en) Method for preparing dihydrodaidzein
BE833732A (en) OXIDIZATION CATALYST AND ITS USE FOR THE MANUFACTURE OF METHACRYLIC ACID
KR950009368B1 (en) Process for preparing ketocholanates
Salnikova et al. Phenyl Substituted Porphyrins. Part 4. Acylation of Hydroxyphenylporphyrins
CN116135846A (en) Preparation method and application of nile red and derivatives thereof
CN116621704A (en) Preparation method of 2, 3-dimethyl-4-nitrobenzoic acid
CN116023331A (en) Synthesis method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid
CA2086321A1 (en) Cyclohexene derivative and method of producing the same
CN112759556A (en) Synthetic method for preparing 5-mercapto-1, 2, 3-triazole sodium salt by one-pot method
CN117603149A (en) Resmetirom intermediate and preparation method thereof as well as preparation method of key intermediate III
CN117586255A (en) Oral ATP competitive kinase inhibitor and synthesis method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22964994

Country of ref document: EP

Kind code of ref document: A1